| 1 | Intravascular lithotripsy for the treatment of peri-stent calcific lesions in saphenous vein grafts: A case series report | 0.7 | 3 | Citations (PDF) |
| 2 | EPA Induces an Anti-Inflammatory Transcriptome in T Cells, Implicating a Triglyceride-Independent Pathway in Cardiovascular Risk Reduction | 3.3 | 7 | Citations (PDF) |
| 3 | Unilateral-access vs. bilateral-access in transfemoral transcatheter aortic valve replacement: A slim fit approach | 2.2 | 4 | Citations (PDF) |
| 4 | Risk of cardiovascular disease in elderly subjects with obesity and liver fibrosis and the potential benefit of statin treatment | 3.0 | 4 | Citations (PDF) |
| 5 | Epicardial fat tissue, a hidden enemy against the early recovery of left ventricular systolic function after transcatheter aortic valve implantation | 0.7 | 0 | Citations (PDF) |
| 6 | Increased prevalence of coronary atherosclerosis in cancer survivors: A retrospective matched cross-sectional study with coronary CT angiography | 2.9 | 4 | Citations (PDF) |
| 7 | Angiographic Characterization and Sex‐Related Anatomical Differences of Atrial Coronary Arteries Anatomy—A Proposal of Systematic Classification | 1.7 | 0 | Citations (PDF) |
| 8 | Symptomatic early coronary graft failure in bypass surgery patients: incidence, predictors and clinical impact | 1.3 | 1 | Citations (PDF) |
| 9 | Efficacy of a novel PCSK9 inhibitory peptide alone and with evinacumab in a mouse model of atherosclerosis | 3.6 | 5 | Citations (PDF) |
| 10 | Pravastatin reduces all-cause mortality in elderly individuals at risk of liver fibrosis: Post hoc analysis of the PROSPER trial | 4.5 | 1 | Citations (PDF) |
| 11 | Potential causal evidence for an ApoB-independent and HDL-related risk profile associated with coronary artery disease | 3.6 | 0 | Citations (PDF) |
| 12 | Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES | 18.0 | 24 | Citations (PDF) |
| 13 | Defibrillation Threshold Testing After ICD Implantation in Patients with Chronic Kidney Disease | 2.3 | 0 | Citations (PDF) |
| 14 | The interactions of Lipoprotein(a) with common cardiovascular risk factors in cardiovascular disease risk: evidence based on the UK Biobank | 2.8 | 4 | Citations (PDF) |
| 15 | Fibrogenic Gene Signature as Early Prediction for the Efficacy of Pharmacological Interventions for
<scp>MASH</scp>
‐Associated Fibrosis | 0.6 | 3 | Citations (PDF) |
| 16 | Echocardiographic effects of sodium-glucose cotransporter 2 inhibitors in single ventricle circulatory failure | 0.6 | 4 | Citations (PDF) |
| 17 | Intravascular Lithotripsy for Calcific Coronary Bifurcations: Procedural Success and 1‐Year Clinical Outcomes | 1.7 | 1 | Citations (PDF) |
| 18 | CD137 Signaling Modulates Vein Graft Atherosclerosis by Driving T-Cell Activation and Regulating Intraplaque Angiogenesis | 3.3 | 0 | Citations (PDF) |
| 19 | Diagnosis and Treatment of Unrecognized Spontaneous Coronary Artery Dissection in Young Women Presenting With an Acute Coronary Syndrome | 1.8 | 3 | Citations (PDF) |
| 20 | Triglycerides and T Cells in Cardiovascular Risk | 3.3 | 3 | Citations (PDF) |
| 21 | Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of 3 Tests | 18.0 | 52 | Citations (PDF) |
| 22 | Quality control to improve LDL-cholesterol management in patients with acute coronary syndromes based on the ACS EuroPath IV project | 1.0 | 5 | Citations (PDF) |
| 23 | The potential benefit of statin prescription based on prediction of treatment responsiveness in older individuals: an application to the PROSPER randomized controlled trial | 2.0 | 4 | Citations (PDF) |
| 24 | Statin pretreatment and cardiac surgery: end of a myth? | 1.2 | 0 | Citations (PDF) |
| 25 | Multi-trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications | 13.7 | 15 | Citations (PDF) |
| 26 | Multi-trait analysis characterizes the genetics of thyroid function and identifies causal associations with clinical implications | 13.7 | 52 | Citations (PDF) |
| 27 | A genetic association study of circulating coagulation factor VIII and von Willebrand factor levelsBlood, 2024, 143, 1845-1855 | 4.8 | 23 | Citations (PDF) |
| 28 | The Clear Value of Coronary Artery Calcification Evaluation on Non-Gated Chest Computed Tomography for Cardiac Risk Stratification | 2.3 | 8 | Citations (PDF) |
| 29 | Atypical Progeria Primarily Manifesting as Premature Cardiac Valvular Disease Segregates with LMNA-Gene Variants | 1.4 | 3 | Citations (PDF) |
| 30 | Genome-wide characterization of circulating metabolic biomarkers | 37.9 | 237 | Citations (PDF) |
| 31 | Effects of repeated weight cycling on non‐alcoholic steatohepatitis in diet‐induced obese mice | 0.6 | 5 | Citations (PDF) |
| 32 | Coronary artery calcium assessment on non-gated chest CT to optimize pre-operative cardiac screening in liver transplantation | 2.2 | 4 | Citations (PDF) |
| 33 | Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation | 4.0 | 21 | Citations (PDF) |
| 34 | Coronary calcifications as assessed on routine non-gated chest CT; a gatekeeper to tailor downstream additional imaging in patients with stable chest pain | 0.7 | 2 | Citations (PDF) |
| 35 | CCL18 aggravates atherosclerosis by inducing CCR6-dependent T-cell influx and polarization | 4.9 | 18 | Citations (PDF) |
| 36 | Efficacy of the Cardiac Implantable Electronic Device Multisensory Triage-HF Algorithm in Heart Failure Care: A Real-World Clinical Experience | 3.0 | 4 | Citations (PDF) |
| 37 | Coronary calcified nodules versus nonnodular coronary calcifications: a systematic review and meta-analysis | 1.2 | 7 | Citations (PDF) |
| 38 | Comparison of left ventricular mass and wall thickness between cardiac computed tomography angiography and cardiac magnetic resonance imaging using machine learning algorithms 2024, 2, | | 4 | Citations (PDF) |
| 39 | Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials | 1.5 | 36 | Citations (PDF) |
| 40 | Estimating uncertainty when providing individual cardiovascular risk predictions: a Bayesian survival analysis | 3.7 | 3 | Citations (PDF) |
| 41 | Pericoronary adipose tissue for predicting long-term outcomes | 1.4 | 27 | Citations (PDF) |
| 42 | The impact of statin use on sepsis mortality | 3.1 | 14 | Citations (PDF) |
| 43 | Genome‐Wide Interaction Analyses of Serum Calcium on Ventricular Repolarization Time in 125 393 Participants | 4.0 | 0 | Citations (PDF) |
| 44 | Whole-genome analysis of plasma fibrinogen reveals population-differentiated genetic regulators with putative liver rolesBlood, 2024, 144, 2248-2265 | 4.8 | 13 | Citations (PDF) |
| 45 | Increased 1H-NMR metabolomics-based health score associates with declined cognitive performance and functional independence in older adults at risk of cardiovascular disease | 4.6 | 13 | Citations (PDF) |
| 46 | Therapeutic effects of
FGF21
mimetic
bFKB1
on
MASH
and atherosclerosis in Ldlr−/−.Leiden mice | 0.6 | 3 | Citations (PDF) |
| 47 | Treatment and low-density lipoprotein cholesterol levels in patients with hypercholesterolaemia or mixed dyslipidaemia at high or very high cardiovascular risk: a population-based cross-sectional study in the Netherlands | 2.1 | 2 | Citations (PDF) |
| 48 | Efficacy and Safety of Intravascular Lithotripsy Versus Rotational Atherectomy in Balloon-Crossable Heavily Calcified Coronary Lesions | 0.7 | 18 | Citations (PDF) |
| 49 | Setting your clock: associations between timing of objective physical activity and cardiovascular disease risk in the general population | 2.0 | 78 | Citations (PDF) |
| 50 | Low leukocyte mitochondrial DNA abundance drives atherosclerotic cardiovascular diseases: a cohort and Mendelian randomization study | 5.5 | 18 | Citations (PDF) |
| 51 | Weight loss, visit-to-visit body weight variability and cognitive function in older individuals | 1.8 | 12 | Citations (PDF) |
| 52 | The effect of the 2019 ESC/EAS dyslipidaemia guidelines on low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS EuroPath IV project | 2.5 | 29 | Citations (PDF) |
| 53 | Cardiac and obstetric outcomes of pregnancies for women after cardiotoxic therapy in childhood: a single center observational study | 2.9 | 2 | Citations (PDF) |
| 54 | Pericoronary Adipose Tissue Attenuation in Patients With Acute Coronary Syndrome Versus Stable Coronary Artery Disease | 2.9 | 57 | Citations (PDF) |
| 55 | Impact of Age at Diagnosis on Cardiotoxicity in High-Grade Osteosarcoma and Ewing Sarcoma Patients | 4.6 | 9 | Citations (PDF) |
| 56 | Lipid-induced transcriptomic changes in blood link to lipid metabolism and allergic response | 13.7 | 16 | Citations (PDF) |
| 57 | Addressing current challenges in optimization of lipid management following an ACS event: Outcomes of the ACS EuroPath III initiative | 2.0 | 13 | Citations (PDF) |
| 58 | Intra-Individual Comparison of Sinus and Ectopic Beats Probing the Ventricular Gradient’s Activation Dependence | 1.4 | 0 | Citations (PDF) |
| 59 | Coronary calcium score in COVID-19 survivors: Association with cardiac injury and cardiac function after 6 weeks | 0.6 | 1 | Citations (PDF) |
| 60 | The association between leptin and subclinical cardiovascular disease explained by body fat: Observational and Mendelian randomization analyses | 3.2 | 3 | Citations (PDF) |
| 61 | Feasibility of Community Pharmacist-Initiated and Point-of-Care CYP2C19 Genotype-Guided De-Escalation of Oral P2Y12 Inhibitors | 2.5 | 11 | Citations (PDF) |
| 62 | Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial | 2.2 | 23 | Citations (PDF) |
| 63 | Anomalous Aortic Origin of the Right Coronary Artery: Invasive Haemodynamic Assessment in Adult Patients With High-Risk Anatomic Features | 0.8 | 9 | Citations (PDF) |
| 64 | Genetic architecture of spatial electrical biomarkers for cardiac arrhythmia and relationship with cardiovascular disease | 13.7 | 15 | Citations (PDF) |
| 65 | Contemporary Management Strategies of Baffle Leaks in Adults with a Failing Systemic Right Ventricle Late after Atrial Switch: A Case Series and Literature Overview | 1.4 | 2 | Citations (PDF) |
| 66 | Atorvastatin Attenuates Diet-Induced Non-Alcoholic Steatohepatitis in APOE*3-Leiden Mice by Reducing Hepatic Inflammation | 4.4 | 17 | Citations (PDF) |
| 67 | Atrioventricular nodal reentry tachycardia in pregnancy: ‘I have ice for you’ | 0.5 | 0 | Citations (PDF) |
| 68 | Effect of alirocumab on cataracts in patients with acute coronary syndromes | 1.6 | 5 | Citations (PDF) |
| 69 | Exploring the possible causal effects of cardiac blood biomarkers in dementia and cognitive performance: a Mendelian randomization study | 4.6 | 11 | Citations (PDF) |
| 70 | The Effect of Intravascular Lithotripsy on Cardiac Implantable Electronic Device Function | 3.0 | 2 | Citations (PDF) |
| 71 | Cardiovascular risk factors and major recurrent coronary events: A genetic liability study in patients with coronary artery disease in the UK Biobank | 1.5 | 1 | Citations (PDF) |
| 72 | The potential of sodium-glucose cotransporter 2 inhibitors for the treatment of systemic right ventricular failure in adults with congenital heart disease | 2.4 | 27 | Citations (PDF) |
| 73 | Prognostic value of left ventricular myocardial work indices in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement | 1.4 | 22 | Citations (PDF) |
| 74 | Plaque Rupture in a Hodgkin Lymphoma Survivor without Cardiovascular Risk Factors 20 Years after Thoracic Radiotherapy: A Case Report | 1.4 | 1 | Citations (PDF) |
| 75 | Valvular heart disease and cardiomyopathy: reappraisal of their interplay | 35.5 | 19 | Citations (PDF) |
| 76 | Genetic insights into resting heart rate and its role in cardiovascular disease | 13.7 | 33 | Citations (PDF) |
| 77 | Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial | 4.0 | 37 | Citations (PDF) |
| 78 | Evaluation of Clinical Applicability of Coronary Artery Calcium Assessment on Non–Gated Chest Computed Tomography, Compared With the Classic Agatston Score on Cardiac Computed Tomography | 1.8 | 10 | Citations (PDF) |
| 79 | High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicine | 2.4 | 34 | Citations (PDF) |
| 80 | Automatic Quantification of Local Plaque Thickness Differences as Assessed by Serial Coronary Computed Tomography Angiography Using Scan-Quality-Based Vessel-Specific Thresholds | 2.3 | 0 | Citations (PDF) |
| 81 | Relation between Coronary Artery Calcium Score and Cardiovascular Events in Hodgkin Lymphoma Survivors: A Cross-Sectional Matched Cohort Study | 3.8 | 5 | Citations (PDF) |
| 82 | Associations of metabolomic profiles with circulating vitamin E and urinary vitamin E metabolites in middle-aged individuals | 2.7 | 4 | Citations (PDF) |
| 83 | Bailout Intravascular Lithotripsy for the Treatment of Acutely Underexpanded Stents in Heavily Calcified Coronary Lesions: A Case Series | 0.7 | 9 | Citations (PDF) |
| 84 | Association of cognitive function with increased risk of cancer death and all-cause mortality: Longitudinal analysis, systematic review, and meta-analysis of prospective observational studies | 2.3 | 14 | Citations (PDF) |
| 85 | Utilizing (serial) coronary computed tomography angiography (CCTA) to predict plaque progression and major adverse cardiac events (MACE): results, merits and challenges | 3.6 | 16 | Citations (PDF) |
| 86 | Interfering in the ALK1 Pathway Results in Macrophage-Driven Outward Remodeling of Murine Vein Grafts | 2.4 | 9 | Citations (PDF) |
| 87 | Correlation between quantification of myocardial area at risk and ischemic burden at cardiac computed tomography | 2.5 | 6 | Citations (PDF) |
| 88 | Nuclear medicine imaging methods of radiation-induced cardiotoxicity | 4.9 | 13 | Citations (PDF) |
| 89 | Transmural ischemia visualized using routine Chest CTA | 0.6 | 0 | Citations (PDF) |
| 90 | Alirocumab after acute coronary syndrome in patients with a history of heart failure | 2.2 | 37 | Citations (PDF) |
| 91 | Impaired Global Longitudinal Strain Is Associated with Cardiovascular Events in Hodgkin Lymphoma Survivors | 3.8 | 2 | Citations (PDF) |
| 92 | Performance of a HeartLogicTM Based Care Path in the Management of a Real-World Chronic Heart Failure Population | 2.4 | 15 | Citations (PDF) |
| 93 | Pharmacogenetics-guided dalcetrapib therapy after an acute coronary syndrome: the dal-GenE trial | 2.2 | 35 | Citations (PDF) |
| 94 | Setting your clock: associations of physical activity timing with cardiovascular disease risk | 1.6 | 1 | Citations (PDF) |
| 95 | Genome-wide meta-analyses reveal novel loci for verbal short-term memory and learning | 7.8 | 19 | Citations (PDF) |
| 96 | Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab | 18.0 | 98 | Citations (PDF) |
| 97 | Metabolomic profiles predict individual multidisease outcomes | 33.0 | 369 | Citations (PDF) |
| 98 | Stroke genetics informs drug discovery and risk prediction across ancestries | 37.9 | 561 | Citations (PDF) |
| 99 | Genetic analyses of the electrocardiographic QT interval and its components identify additional loci and pathways | 13.7 | 49 | Citations (PDF) |
| 100 | Systemic thrombolysis in the management of pump thrombosis in patients with left ventricular assist devices | 2.4 | 7 | Citations (PDF) |
| 101 | Cardiotoxicity in Ewing- and osteosarcoma: a 40 year experience from a tertiary sarcoma center | 2.2 | 1 | Citations (PDF) |
| 102 | Automatic quantification of plaque progression dynamics as assessed by serial coronary computed tomography angiography using scan-quality-based vessel specific thresholds | 2.2 | 0 | Citations (PDF) |
| 103 | Phosphorylcholine Monoclonal Antibody Therapy Decreases Intraplaque Angiogenesis and Intraplaque Hemorrhage in Murine Vein Grafts | 4.4 | 6 | Citations (PDF) |
| 104 | Cardiac Troponin, Cognitive Function, and Dementia: A Systematic Review 2022 | | 6 | Citations (PDF) |
| 105 | Comparison of P2Y12 receptor inhibitors in patients with ST-elevation myocardial infarction in clinical practice: a propensity score analysis of five contemporary European registries | 4.0 | 18 | Citations (PDF) |
| 106 | Intensity of statin treatment after acute coronary syndrome, residual risk, and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial | 2.0 | 51 | Citations (PDF) |
| 107 | Association of Circulating Metabolites in Plasma or Serum and Risk of Stroke | 1.0 | 42 | Citations (PDF) |
| 108 | Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseases | 7.3 | 19 | Citations (PDF) |
| 109 | Interplay of circulating leptin and obesity in cognition and cerebral volumes in older adults | 2.8 | 9 | Citations (PDF) |
| 110 | A case of tortuous anatomy: cervical aortic arch | 2.2 | 0 | Citations (PDF) |
| 111 | Associations of Cytomegalovirus Infection With All-Cause and Cardiovascular Mortality in Multiple Observational Cohort Studies of Older Adults | 3.7 | 49 | Citations (PDF) |
| 112 | P300/CBP Associated Factor (PCAF) Deficiency Enhances Diet-Induced Atherosclerosis in ApoE3*Leiden Mice via Systemic Inhibition of Regulatory T Cells | 2.4 | 9 | Citations (PDF) |
| 113 | Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability | 13.7 | 137 | Citations (PDF) |
| 114 | Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence? | 3.4 | 131 | Citations (PDF) |
| 115 | Genome-wide association study of circulating interleukin 6 levels identifies novel loci | 2.9 | 55 | Citations (PDF) |
| 116 | New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention? | 1.5 | 70 | Citations (PDF) |
| 117 | The impact of transvenous cardioverter-defibrillator implantation on quality of life, depression and optimism in dialysis patients: report on the secondary outcome of QOL in the randomized controlled ICD2 trial | 2.1 | 4 | Citations (PDF) |
| 118 | Atorvastatin pleiotropically decreases intraplaque angiogenesis and intraplaque haemorrhage by inhibiting ANGPT2 release and VE-Cadherin internalization | 7.3 | 30 | Citations (PDF) |
| 119 | The Inflammatory Profile of CTEPH-Derived Endothelial Cells Is a Possible Driver of Disease Progression | 4.6 | 32 | Citations (PDF) |
| 120 | Common Genetic Variation in MC4R Does Not Affect Atherosclerotic Plaque Phenotypes and Cardiovascular Disease Outcomes | 2.5 | 3 | Citations (PDF) |
| 121 | Genetically determined NLRP3 inflammasome activation associates with systemic inflammation and cardiovascular mortality | 2.2 | 91 | Citations (PDF) |
| 122 | Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment | 6.2 | 34 | Citations (PDF) |
| 123 | Clinical Efficacy and Safety of Alirocumab After Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol | 18.0 | 82 | Citations (PDF) |
| 124 | Investigating the relationships between unfavourable habitual sleep and metabolomic traits: evidence from multi-cohort multivariable regression and Mendelian randomization analyses | 7.1 | 25 | Citations (PDF) |
| 125 | The first multicentre study on coronary anomalies in the Netherlands: MuSCAT | 1.3 | 12 | Citations (PDF) |
| 126 | Normal and reference values for cardiovascular magnetic resonance-based pulse wave velocity in the middle-aged general population | 4.3 | 37 | Citations (PDF) |
| 127 | Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib | 2.9 | 13 | Citations (PDF) |
| 128 | Levothyroxine Treatment and Cardiovascular Outcomes in Older People With Subclinical Hypothyroidism: Pooled Individual Results of Two Randomised Controlled Trials | 3.8 | 38 | Citations (PDF) |
| 129 | The trans-ancestral genomic architecture of glycemic traits | 25.2 | 685 | Citations (PDF) |
| 130 | Phosphorylcholine antibodies restrict infarct size and left ventricular remodelling by attenuating the unreperfused post‐ischaemic inflammatory response | 4.0 | 6 | Citations (PDF) |
| 131 | Quantification of myocardial ischemia and subtended myocardial mass at adenosine stress cardiac computed tomography: a feasibility study | 1.2 | 2 | Citations (PDF) |
| 132 | Genetically Determined Serum Calcium Levels and Markers of Ventricular Repolarization: A Mendelian Randomization Study in the UK Biobank | 2.9 | 19 | Citations (PDF) |
| 133 | SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe | 2.2 | 1,486 | Citations (PDF) |
| 134 | Differential insulin sensitivity of NMR-based metabolomic measures in a two-step hyperinsulinemic euglycemic clamp study | 2.8 | 3 | Citations (PDF) |
| 135 | Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies | 7.1 | 46 | Citations (PDF) |
| 136 | Identification of Sex-Specific Biomarkers Predicting New-Onset Heart Failure | 3.1 | 17 | Citations (PDF) |
| 137 | Differential effect of statin use on coagulation markers: an active comparative analysis in the NEO study | 2.0 | 13 | Citations (PDF) |
| 138 | Prognostic Value of Natriuretic Peptides for All-Cause Mortality, Right Ventricular Failure, Major Adverse Events, and Myocardial Recovery in Advanced Heart Failure Patients Receiving a Left Ventricular Assist Device: A Systematic Review | 2.4 | 7 | Citations (PDF) |
| 139 | Estimated pulse wave velocity (ePWV) as a potential gatekeeper for MRI-assessed PWV: a linear and deep neural network based approach in 2254 participants of the Netherlands Epidemiology of Obesity study | 1.2 | 13 | Citations (PDF) |
| 140 | Effects of fatty acids on T cell function: role in atherosclerosis | 35.5 | 46 | Citations (PDF) |
| 141 | The challenge of choosing in cardiovascular risk management | 1.3 | 6 | Citations (PDF) |
| 142 | Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients | 2.2 | 6 | Citations (PDF) |
| 143 | 2020 ESC Guidelines on acute coronary syndrome without ST-segment elevation | 1.3 | 19 | Citations (PDF) |
| 144 | Triglyceride-lowering LPL alleles combined with LDL-C-lowering alleles are associated with an additively improved lipoprotein profile | 1.5 | 11 | Citations (PDF) |
| 145 | Higher thyroid stimulating hormone leads to cardiovascular disease and an unfavorable lipid profile: EVidence from multi-cohort Mendelian randomization and metabolomic profiling | 1.5 | 0 | Citations (PDF) |
| 146 | Dietary-derived antioxidants do not decrease the risk of ischemic stroke: A Mendelian randomization study | 1.5 | 0 | Citations (PDF) |
| 147 | Classical risk factors for primary coronary artery disease from an ageing perspective through Mendelian randomization | 1.5 | 0 | Citations (PDF) |
| 148 | Relative risk of thrombo-embolisms and major bleedings is high in left ventricular assist device patients with unstable anticoagulation control | 1.5 | 0 | Citations (PDF) |
| 149 | Investigating the relationships between unfavorable sleep and metabolomic traits: Evidence from multi-cohort multivariable regression and mendelian randomization analyses | 1.5 | 0 | Citations (PDF) |
| 150 | Fatty acid-induced transcriptomic and methylomic changes in T-cells are involved in immunometabolism | 1.5 | 0 | Citations (PDF) |
| 151 | Differential insulin sensitivity of NMR-based metabolomic measures in a two-step hyperinsulinemic euglycemic clamp study | 1.5 | 0 | Citations (PDF) |
| 152 | Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol | 2.3 | 138 | Citations (PDF) |
| 153 | Association of Thyroid Dysfunction With Cognitive Function | 10.6 | 105 | Citations (PDF) |
| 154 | The Genomics of Heart Failure: Design and Rationale of the HERMES Consortium | 3.1 | 23 | Citations (PDF) |
| 155 | Mendelian randomization study of the relation between adiponectin and heart function, unravelling the paradox | 2.8 | 10 | Citations (PDF) |
| 156 | EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study | 2.0 | 720 | Citations (PDF) |
| 157 | COVID-19 associated perimyocarditis | 1.8 | 2 | Citations (PDF) |
| 158 | Original Research: Long-Term Prognosis After ST-Elevation Myocardial Infarction in Patients with a Prior Cancer Diagnosis | 2.3 | 0 | Citations (PDF) |
| 159 | Identification of Functional Genetic Determinants of Cardiac Troponin T and I in a Multiethnic Population and Causal Associations With Atrial Fibrillation | 2.9 | 15 | Citations (PDF) |
| 160 | Higher thyrotropin leads to unfavorable lipid profile and somewhat higher cardiovascular disease risk: evidence from multi-cohort Mendelian randomization and metabolomic profiling | 7.1 | 25 | Citations (PDF) |
| 161 | Cold-Inducible RNA-Binding Protein but Not Its Antisense lncRNA Is a Direct Negative Regulator of Angiogenesis In Vitro and In Vivo via Regulation of the 14q32 angiomiRs—microRNA-329-3p and microRNA-495-3p | 4.4 | 10 | Citations (PDF) |
| 162 | Diet‐Derived Antioxidants Do Not Decrease Risk of Ischemic Stroke: A Mendelian Randomization Study in 1 Million People | 4.0 | 21 | Citations (PDF) |
| 163 | The power of genetic diversity in genome-wide association studies of lipids | 37.9 | 923 | Citations (PDF) |
| 164 | Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure | 13.7 | 776 | Citations (PDF) |
| 165 | Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome | 2.3 | 487 | Citations (PDF) |
| 166 | Heritability estimates for 361 blood metabolites across 40 genome-wide association studies | 13.7 | 96 | Citations (PDF) |
| 167 | Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice | 3.6 | 64 | Citations (PDF) |
| 168 | Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis | 2.2 | 80 | Citations (PDF) |
| 169 | Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial | 2.2 | 191 | Citations (PDF) |
| 170 | Ticagrelor Versus Clopidogrel in Older Patients with NSTE-ACS Using Oral Anticoagulation: A Sub-Analysis of the POPular Age Trial | 2.5 | 6 | Citations (PDF) |
| 171 | Prediction Power on Cardiovascular Disease of Neuroimmune Guidance Cues Expression by Peripheral Blood Monocytes Determined by Machine-Learning Methods | 4.4 | 5 | Citations (PDF) |
| 172 | The role of insulin resistance in the relation of visceral, abdominal subcutaneous and total body fat to cardiovascular function | 3.2 | 8 | Citations (PDF) |
| 173 | Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals | 25.2 | 177 | Citations (PDF) |
| 174 | Improving lipid management in patients with acute coronary syndrome: The acs lipid europath tool | 1.5 | 0 | Citations (PDF) |
| 175 | Metabolic Age Based on the BBMRI-NL
1
H-NMR Metabolomics Repository as Biomarker of Age-related Disease | 2.9 | 107 | Citations (PDF) |
| 176 | Association of common genetic variants with brain microbleeds | 1.0 | 90 | Citations (PDF) |
| 177 | Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial | 2.2 | 65 | Citations (PDF) |
| 178 | Cerebral small vessel disease genomics and its implications across the lifespan | 13.7 | 198 | Citations (PDF) |
| 179 | Goede prognose voor terugverwezen hartinfarctpatiënten | 0.0 | 0 | Citations (PDF) |
| 180 | An individual participant data analysis of prospective cohort studies on the association between subclinical thyroid dysfunction and depressive symptoms | 3.4 | 29 | Citations (PDF) |
| 181 | Myostatin Inhibits Vascular Smooth Muscle Cell Proliferation and Local 14q32 microRNA Expression, But Not Systemic Inflammation or Restenosis | 4.4 | 18 | Citations (PDF) |
| 182 | Cost-Effectiveness of Alirocumab in Patients With Acute Coronary Syndromes | 2.3 | 60 | Citations (PDF) |
| 183 | Multi-ancestry GWAS of the electrocardiographic PR interval identifies 202 loci underlying cardiac conduction | 13.7 | 111 | Citations (PDF) |
| 184 | Association of High-Density Lipoprotein Cholesterol With Cognitive Function: Findings From the PROspective Study of Pravastatin in the Elderly at Risk | 1.9 | 9 | Citations (PDF) |
| 185 | Optical Coherence Tomography: Current Applications for the Assessment of Coronary Artery Disease and Guidance of Percutaneous Coronary Interventions | 2.3 | 35 | Citations (PDF) |
| 186 | Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities | 5.9 | 114 | Citations (PDF) |
| 187 | The association of kidney function and cognitive decline in older patients at risk of cardiovascular disease: a longitudinal data analysis | 2.1 | 22 | Citations (PDF) |
| 188 | Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome | 18.0 | 181 | Citations (PDF) |
| 189 | Blood transfusion and ischaemic outcomes according to anemia and bleeding in patients with non-ST-segment elevation acute coronary syndromes: Insights from the TAO randomized clinical trial | 2.2 | 5 | Citations (PDF) |
| 190 | Effect of No Prehydration vs Sodium Bicarbonate Prehydration Prior to Contrast-Enhanced Computed Tomography in the Prevention of Postcontrast Acute Kidney Injury in Adults With Chronic Kidney Disease | 10.6 | 59 | Citations (PDF) |
| 191 | The association between leptin concentration and blood coagulation: Results from the NEO study | 2.3 | 12 | Citations (PDF) |
| 192 | Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial | 62.1 | 320 | Citations (PDF) |
| 193 | Ventricular Repolarization is Associated with Cognitive Function, but Not with Cognitive Decline and Brain Magnetic Resonance Imaging (MRI) Measurements in Older Adults | 2.5 | 10 | Citations (PDF) |
| 194 | The Role of Immunomodulation in Vein Graft Remodeling and Failure | 2.0 | 22 | Citations (PDF) |
| 195 | Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway project | 3.1 | 32 | Citations (PDF) |
| 196 | Phosphorylcholine Antibodies Preserve Cardiac Function and Reduce Infarct Size by Attenuating the Post-Ischemic Inflammatory Response | 3.3 | 10 | Citations (PDF) |
| 197 | Improving lipid management in patients with acute coronary syndrome: The ACS Lipid EuroPath tool | 3.1 | 12 | Citations (PDF) |
| 198 | Inhibition of BMP9 and BMP10 signalling by the ALK1-Fc Ligand Trap enhances systemic inflammation and increases vein graft atherosclerosis | 2.2 | 0 | Citations (PDF) |
| 199 | Normal and reference values for MRI-based pulse wave velocity in the middle-aged general population | 2.2 | 0 | Citations (PDF) |
| 200 | Effect of alirocumab on incidence of atrial fibrillation after acute coronary syndromes: insights from ODYSSEY OUTCOMES | 2.2 | 0 | Citations (PDF) |
| 201 | Prognostic Importance of Increased Right Ventricular Afterload in Orthotopic Liver Transplantation Recipients With Endstage Cirrhosis | 0.9 | 5 | Citations (PDF) |
| 202 | Blockade of vascular endothelial growth factor receptor 2 inhibits intraplaque haemorrhage by normalization of plaque neovessels | 7.3 | 62 | Citations (PDF) |
| 203 | A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals | 13.7 | 320 | Citations (PDF) |
| 204 | Subclinical thyroid dysfunction and depressive symptoms: protocol for a systematic review and individual participant data meta-analysis of prospective cohort studies | 1.9 | 5 | Citations (PDF) |
| 205 | Characterization of the left ventricular arrhythmogenic substrate with multimodality imaging: role of innervation imaging and left ventricular global longitudinal strain | 1.1 | 2 | Citations (PDF) |
| 206 | Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome | 2.3 | 227 | Citations (PDF) |
| 207 | CD8+ T Cells Protect During Vein Graft Disease Development | 2.4 | 7 | Citations (PDF) |
| 208 | Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial | 21.7 | 281 | Citations (PDF) |
| 209 | Effects of Calcium, Magnesium, and Potassium Concentrations on Ventricular Repolarization in Unselected Individuals | 2.3 | 37 | Citations (PDF) |
| 210 | Electrocardiographic Detection of Left Ventricular Hypertrophy; Adding Body Mass Index and Spatial QRS-T Angle: A Cross-Sectional Study | 2.3 | 11 | Citations (PDF) |
| 211 | Response by Timal and Jukema to Letter Regarding Article, “Random Controlled Trials of Sudden Cardiac Death: Use of Autopsy to Refine Sudden Cardiac Death Outcomes” | 18.0 | 0 | Citations (PDF) |
| 212 | Associations of autozygosity with a broad range of human phenotypes | 13.7 | 120 | Citations (PDF) |
| 213 | Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial | 4.1 | 22 | Citations (PDF) |
| 214 | Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES | 18.0 | 128 | Citations (PDF) |
| 215 | Cognitive Function in Dementia-Free Subjects and Survival in Old Age: The PROSPER Study | 2.0 | 8 | Citations (PDF) |
| 216 | Genome-Wide Association Study on the Early-Phase Insulin Response to a Liquid Mixed Meal: Results From the NEO Study | 4.2 | 12 | Citations (PDF) |
| 217 | Myocardial infarction patients referred to the primary care physician after 1‑year treatment according to a guideline-based protocol have a good prognosis | 1.3 | 2 | Citations (PDF) |
| 218 | World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions | 13.3 | 988 | Citations (PDF) |
| 219 | Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery | 2.3 | 68 | Citations (PDF) |
| 220 | Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes | 18.0 | 44 | Citations (PDF) |
| 221 | Relationship between coronary artery calcification and myocardial ischemia on computed tomography myocardial perfusion in patients with stable chest pain | 1.8 | 4 | Citations (PDF) |
| 222 | Repeat variations in polyglutamine disease–associated genes and cognitive function in old age | 3.4 | 10 | Citations (PDF) |
| 223 | Genome-Wide Association Study of Apparent Treatment-Resistant Hypertension in the CHARGE Consortium: The CHARGE Pharmacogenetics Working Group | 2.0 | 23 | Citations (PDF) |
| 224 | Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice | 3.8 | 31 | Citations (PDF) |
| 225 | Genome-wide association meta-analysis of 30,000 samples identifies seven novel loci for quantitative ECG traits | 3.0 | 37 | Citations (PDF) |
| 226 | Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials | 62.1 | 708 | Citations (PDF) |
| 227 | Growth Differentiation Factor-15 Levels at Admission Provide Incremental Prognostic Information on All-Cause Long-term Mortality in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention | 2.3 | 11 | Citations (PDF) |
| 228 | Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial | 2.2 | 60 | Citations (PDF) |
| 229 | Human monocyte-to-macrophage differentiation involves highly localized gain and loss of DNA methylation at transcription factor binding sites | 3.2 | 54 | Citations (PDF) |
| 230 | Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure | 4.4 | 87 | Citations (PDF) |
| 231 | The role of inflammation in the association between overall and visceral adiposity and subclinical atherosclerosis | 3.2 | 26 | Citations (PDF) |
| 232 | Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular Disease | 11.1 | 94 | Citations (PDF) |
| 233 | Effect of Alirocumab on Mortality After Acute Coronary Syndromes | 18.0 | 135 | Citations (PDF) |
| 234 | Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease | 2.3 | 24 | Citations (PDF) |
| 235 | Subsequent Event Risk in Individuals With Established Coronary Heart Disease | 2.9 | 19 | Citations (PDF) |
| 236 | Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events | 2.9 | 30 | Citations (PDF) |
| 237 | Metabolomics Profiling of Visceral Adipose Tissue: Results From MESA and the NEO Study | 4.0 | 37 | Citations (PDF) |
| 238 | Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients | 18.0 | 113 | Citations (PDF) |
| 239 | Prevalence of Carriers of Intermediate and Pathological Polyglutamine Disease–Associated Alleles Among Large Population-Based Cohorts | 17.6 | 98 | Citations (PDF) |
| 240 | IRF3 and IRF7 mediate neovascularization via inflammatory cytokines | 4.0 | 20 | Citations (PDF) |
| 241 | Comparison of Diagnostic Performance of Quantitative Flow Ratio in Patients With Versus Without Diabetes Mellitus | 1.8 | 16 | Citations (PDF) |
| 242 | Plasma LDL-Cholesterol Level at Admission is Independently Associated with Infarct Size in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention | 2.3 | 7 | Citations (PDF) |
| 243 | T cell co-stimulation and co-inhibition in cardiovascular disease: a double-edged sword | 35.5 | 82 | Citations (PDF) |
| 244 | Profile of and risk factors for poststroke cognitive impairment in diverse ethnoregional groups | 1.0 | 240 | Citations (PDF) |
| 245 | Survival Bias in Mendelian Randomization Studies | 2.8 | 87 | Citations (PDF) |
| 246 | Borderline Q-waves in individuals without overt cardiovascular disease: Relations with adiposity, subclinical atherosclerosis and vascular stiffness | 2.2 | 4 | Citations (PDF) |
| 247 | Spatial QRS-T Angle and Cognitive Decline in Older Subjects | 2.6 | 13 | Citations (PDF) |
| 248 | Genetic associations and regulation of expression indicate an independent role for 14q32 snoRNAs in human cardiovascular disease | 5.5 | 40 | Citations (PDF) |
| 249 | Referral of patients for fractional flow reserve using quantitative flow ratio | 1.4 | 20 | Citations (PDF) |
| 250 | Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies | 2.2 | 149 | Citations (PDF) |
| 251 | Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels | 18.0 | 159 | Citations (PDF) |
| 252 | Genetic and lifestyle risk factors for MRI-defined brain infarcts in a population-based setting | 1.0 | 43 | Citations (PDF) |
| 253 | Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and Alcohol Use | 5.4 | 86 | Citations (PDF) |
| 254 | Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events | 2.3 | 160 | Citations (PDF) |
| 255 | Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk | 18.0 | 851 | Citations (PDF) |
| 256 | Chest pain in the absence of obstructive coronary artery disease | 2.2 | 7 | Citations (PDF) |
| 257 | Low thyroid function is not associated with an accelerated deterioration in renal function | 0.8 | 40 | Citations (PDF) |
| 258 | Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci | 7.8 | 110 | Citations (PDF) |
| 259 | Indications for an early invasive strategy in NSTE-ACS patients | 1.3 | 11 | Citations (PDF) |
| 260 | Genome-wide meta-analysis of variant-by-diuretic interactions as modulators of lipid traits in persons of European and African ancestry | 2.6 | 6 | Citations (PDF) |
| 261 | Statin-induced LDL cholesterol response and type 2 diabetes: a bidirectional two-sample Mendelian randomization study | 2.6 | 22 | Citations (PDF) |
| 262 | Guidelines for the management of myocardial infarction/injury with non-obstructive coronary arteries (MINOCA): a position paper from the Dutch ACS working group | 1.3 | 57 | Citations (PDF) |
| 263 | PCSK9 inhibition in high-risk patientsAging, 2019, 11, 10791-10792 | 0.9 | 4 | Citations (PDF) |
| 264 | A Rapid (Differential) Effect of Rosuvastatin and Atorvastatin on High‐Sensitivity Cardiac Troponin‐I in Subjects With Stable Cardiovascular Disease | 4.7 | 6 | Citations (PDF) |
| 265 | The role of CD27-CD70-mediated T cell co-stimulation in vasculogenesis, arteriogenesis and angiogenesis | 2.2 | 23 | Citations (PDF) |
| 266 | Prevalence of potentially inappropriate prescribing in a subpopulation of older European clinical trial participants: a cross-sectional study | 1.9 | 27 | Citations (PDF) |
| 267 | Visit-to-visit lipid variability: Clinical significance, effects of lipid-lowering treatment, and (pharmaco) genetics | 3.1 | 18 | Citations (PDF) |
| 268 | Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels | 13.7 | 367 | Citations (PDF) |
| 269 | Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes | 4.6 | 33 | Citations (PDF) |
| 270 | Relation of Overall and Abdominal Adiposity With Electrocardiogram Parameters of Subclinical Cardiovascular Disease in Individuals Aged 45 to 65 Years (from the Netherlands Epidemiology of Obesity Study) | 1.8 | 5 | Citations (PDF) |
| 271 | Determinants of impaired renal and vascular function are associated with elevated levels of procoagulant factors in the general population | 3.8 | 24 | Citations (PDF) |
| 272 | Plasma apolipoprotein-B is an important risk factor for cardiovascular disease, and its assessment should be routine clinical practice | 4.0 | 19 | Citations (PDF) |
| 273 | Annexin A5 reduces infarct size and improves cardiac function after myocardial ischemia-reperfusion injury by suppression of the cardiac inflammatory response | 3.4 | 44 | Citations (PDF) |
| 274 | Associations between normal range albuminuria, renal function and cardiovascular function in a population-based imaging study | 1.5 | 5 | Citations (PDF) |
| 275 | Left Ventricular Mechanical Dispersion and Global Longitudinal Strain and Ventricular Arrhythmias in Predialysis and Dialysis Patients | 3.4 | 24 | Citations (PDF) |
| 276 | Assessment of novel cardiovascular biomarkers in women with a history of recurrent miscarriage | 1.5 | 19 | Citations (PDF) |
| 277 | The mortality benefit seen with the newer more potent oral P2Y12 inhibitors prasugrel and ticagrelor over clopidogrel is dependent on the underlying risk: A class effect as suggested by a meta-regression analysis | 0.2 | 3 | Citations (PDF) |
| 278 | Nuclear Magnetic Resonance-Based Metabolomics Identifies Phenylalanine as a Novel Predictor of Incident Heart Failure Hospitalisation: Results from PROSPER and FINRISK 1997 | 7.3 | 73 | Citations (PDF) |
| 279 | Mendelian randomization analysis of cholesteryl ester transfer protein and subclinical atherosclerosis: A population-based study | 3.1 | 10 | Citations (PDF) |
| 280 | A critical appraisal of pharmacogenetic inference | 2.1 | 8 | Citations (PDF) |
| 281 | Prevalence of Left Ventricular Systolic Dysfunction in Pre-Dialysis and Dialysis Patients with Preserved Left Ventricular Ejection Fraction | 7.3 | 48 | Citations (PDF) |
| 282 | Association of diastolic blood pressure with cardiovascular events in older people varies upon cardiovascular history | 2.1 | 3 | Citations (PDF) |
| 283 | Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease | 18.0 | 735 | Citations (PDF) |
| 284 | O2‐08‐01: COGNITIVE FUNCTION IN DEMENTIA‐FREE SUBJECTS AND SURVIVAL IN OLD AGE | 0.5 | 0 | Citations (PDF) |
| 285 | P2263Diagnostic performance of quantitative flow ratio in diabetic and non-diabetic patients | 2.2 | 1 | Citations (PDF) |
| 286 | Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome | 34.5 | 3,252 | Citations (PDF) |
| 287 | Metabolomic Consequences of Genetic Inhibition of PCSK9 Compared With Statin Treatment | 18.0 | 92 | Citations (PDF) |
| 288 | GWAS and colocalization analyses implicate carotid intima-media thickness and carotid plaque loci in cardiovascular outcomes | 13.7 | 168 | Citations (PDF) |
| 289 | Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps | 25.2 | 1,736 | Citations (PDF) |
| 290 | Genome-wide association study of 23,500 individuals identifies 7 loci associated with brain ventricular volume | 13.7 | 53 | Citations (PDF) |
| 291 | The Relation Between Thyroid Function and Anemia: A Pooled Analysis of Individual Participant Data | 4.0 | 67 | Citations (PDF) |
| 292 | ExomeChip-Wide Analysis of 95 626 Individuals Identifies 10 Novel Loci Associated With QT and JT Intervals | 2.9 | 33 | Citations (PDF) |
| 293 | Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation | 13.7 | 266 | Citations (PDF) |
| 294 | Body fat distribution and genetic variants are associated with sex differences in serum leptin and adiponectin concentrations | 1.5 | 0 | Citations (PDF) |
| 295 | Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders | 6.5 | 427 | Citations (PDF) |
| 296 | Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits | 25.2 | 1,346 | Citations (PDF) |
| 297 | Prevalence and Prognostic Implications of Mitral and Aortic Valve Calcium in Patients With Chronic Kidney Disease | 1.8 | 20 | Citations (PDF) |
| 298 | Appropriate use criteria for optical coherence tomography guidance in percutaneous coronary interventions | 1.3 | 10 | Citations (PDF) |
| 299 | Common and Rare Coding Genetic Variation Underlying the Electrocardiographic PR Interval | 2.9 | 22 | Citations (PDF) |
| 300 | Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function | 13.7 | 650 | Citations (PDF) |
| 301 | HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option? | 2.9 | 41 | Citations (PDF) |
| 302 | Association of complement receptor 1 gene polymorphisms with cognitive function | 2.4 | 3 | Citations (PDF) |
| 303 | Sex differences in body fat distribution are related to sex differences in serum leptin and adiponectin | 2.8 | 111 | Citations (PDF) |
| 304 | PR interval genome-wide association meta-analysis identifies 50 loci associated with atrial and atrioventricular electrical activity | 13.7 | 90 | Citations (PDF) |
| 305 | Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial | 11.1 | 163 | Citations (PDF) |
| 306 | The BCR-ABL1 Inhibitors Imatinib and Ponatinib Decrease Plasma Cholesterol and Atherosclerosis, and Nilotinib and Ponatinib Activate Coagulation in a Translational Mouse Model | 2.4 | 60 | Citations (PDF) |
| 307 | CETP (Cholesteryl Ester Transfer Protein) Concentration | 2.9 | 55 | Citations (PDF) |
| 308 | Increased cardiovascular disease risk in women with a history of recurrent miscarriage | 2.6 | 16 | Citations (PDF) |
| 309 | The protective role of Toll-like receptor 3 and type-I interferons in the pathophysiology of vein graft disease | 3.8 | 12 | Citations (PDF) |
| 310 | Multi-ethnic genome-wide association study for atrial fibrillation | 25.2 | 760 | Citations (PDF) |
| 311 | Association ofLPAVariants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies | 11.1 | 633 | Citations (PDF) |
| 312 | Mendelian randomization reveals unexpected effects of CETP on the lipoprotein profile | 3.0 | 38 | Citations (PDF) |
| 313 | Apolipoproteins A1, B, and apoB/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up | 2.8 | 58 | Citations (PDF) |
| 314 | Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes | 25.2 | 1,600 | Citations (PDF) |
| 315 | Echocardiographic associates of atrial fibrillation in end-stage renal disease | 0.8 | 7 | Citations (PDF) |
| 316 | Novel genetic loci associated with hippocampal volume | 13.7 | 297 | Citations (PDF) |
| 317 | Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk | 25.2 | 580 | Citations (PDF) |
| 318 | Rare and low-frequency coding variants alter human adult height | 37.9 | 622 | Citations (PDF) |
| 319 | Association of fasting triglyceride concentration and postprandial triglyceride response with the carotid intima-media thickness in the middle aged: The Netherlands Epidemiology of Obesity study | 3.1 | 4 | Citations (PDF) |
| 320 | A genome-wide interaction analysis of tricyclic/tetracyclic antidepressants and RR and QT intervals: a pharmacogenomics study from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium | 3.8 | 12 | Citations (PDF) |
| 321 | Abdominal aortic calcification on a plain X-ray and the relation with significant coronary artery disease in asymptomatic chronic dialysis patients | 2.1 | 14 | Citations (PDF) |
| 322 | Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles | 2.0 | 33 | Citations (PDF) |
| 323 | Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increase | 1.5 | 20 | Citations (PDF) |
| 324 | Pathophysiology and treatment of atherosclerosis | 1.3 | 238 | Citations (PDF) |
| 325 | Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease | 2.3 | 248 | Citations (PDF) |
| 326 | Inhibition of 14q32 microRNA miR-495 reduces lesion formation, intimal hyperplasia and plasma cholesterol levels in experimental restenosis | 1.5 | 38 | Citations (PDF) |
| 327 | Discovery of novel heart rate-associated loci using the Exome Chip | 2.9 | 34 | Citations (PDF) |
| 328 | Increasing HDL-C levels with medication: current perspectives | 4.0 | 13 | Citations (PDF) |
| 329 | Left Ventricular Hypertrophy and Cognitive Decline in Old Age | 2.6 | 23 | Citations (PDF) |
| 330 | Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation | 25.2 | 345 | Citations (PDF) |
| 331 | Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus | 18.0 | 364 | Citations (PDF) |
| 332 | Long-term mortality in patients with ST-segment elevation myocardial infarction is associated with anti-citrullinated protein antibodies | 2.2 | 14 | Citations (PDF) |
| 333 | Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits | 13.7 | 201 | Citations (PDF) |
| 334 | Long-Term Prognosis of Patients With Intramural Course of Coronary Arteries Assessed With CT Angiography | 6.1 | 21 | Citations (PDF) |
| 335 | The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice | 2.2 | 215 | Citations (PDF) |
| 336 | Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study | 21.7 | 104 | Citations (PDF) |
| 337 | Is Hepatic Triglyceride Content Associated with Aortic Pulse Wave Velocity and Carotid Intima-Media Thickness? The Netherlands Epidemiology of Obesity Study | 8.7 | 3 | Citations (PDF) |
| 338 | Classical determinants of coronary artery disease as predictors of complexity of
coronary lesions, assessed with the SYNTAX score | 1.3 | 6 | Citations (PDF) |
| 339 | Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism | 34.5 | 459 | Citations (PDF) |
| 340 | Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes | 4.0 | 18 | Citations (PDF) |
| 341 | Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab | 34.5 | 364 | Citations (PDF) |
| 342 | Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients | 34.5 | 584 | Citations (PDF) |
| 343 | Additional Candidate Genes for Human Atherosclerotic Disease Identified Through Annotation Based on Chromatin Organization | 3.8 | 22 | Citations (PDF) |
| 344 | Genome-wide Trans-ethnic Meta-analysis Identifies Seven Genetic Loci Influencing Erythrocyte Traits and a Role for RBPMS in Erythropoiesis | 6.5 | 49 | Citations (PDF) |
| 345 | Prevalence by Computed Tomographic Angiography of Coronary Plaques in South Asian and White Patients With Type 2 Diabetes Mellitus at Low and High Risk Using Four Cardiovascular Risk Scores (UKPDS, FRS, ASCVD, and JBS3) | 1.8 | 19 | Citations (PDF) |
| 346 | Complement receptor 1 gene polymorphisms are associated with cardiovascular risk | 1.5 | 29 | Citations (PDF) |
| 347 | Exome-wide association study of plasma lipids in >300,000 individuals | 25.2 | 552 | Citations (PDF) |
| 348 | No association between CETP concentration and intima media thickness in the general population: The Neo study | 1.5 | 0 | Citations (PDF) |
| 349 | Cardiovascular safety of BCR-ABL1 tyrosine kinase inhibitors: imatinib and ponatinib decrease plasma cholesterol and atherosclerosis in APOE3*Leiden.CETP Mice | 1.5 | 0 | Citations (PDF) |
| 350 | Genome-wide meta-analysis associates HLA-DQA1/DRB1 and LPA and lifestyle factors with human longevity | 13.7 | 166 | Citations (PDF) |
| 351 | Metabolic syndrome is associated with electrocardiographic markers of subclinical cardiovascular disease | 1.5 | 0 | Citations (PDF) |
| 352 | Low levels of apolipoprotein-CII in normotriglyceridemic patients with very premature coronary artery disease: Observations from the MISSION! Intervention study | 3.1 | 13 | Citations (PDF) |
| 353 | Body fat distribution, in particular visceral fat, is associated with cardiometabolic risk factors in women with obesity | 1.5 | 6 | Citations (PDF) |
| 354 | Genetic Interactions with Age, Sex, Body Mass Index, and Hypertension in Relation to Atrial Fibrillation: The AFGen Consortium | 3.4 | 18 | Citations (PDF) |
| 355 | MILANO-PILOT: will infusing HDL mimetics containing apoA-imilano continue to regress coronary atherosclerosis in the modern era of intensive statin therapy? | 1.5 | 0 | Citations (PDF) |
| 356 | A protective role of IRF3 and IRF7 signalling downstream TLRs in the development of vein graft disease via type I interferons | 7.3 | 16 | Citations (PDF) |
| 357 | High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants | 2.3 | 273 | Citations (PDF) |
| 358 | Novel Blood Pressure Locus and Gene Discovery Using Genome-Wide Association Study and Expression Data Sets From Blood and the Kidney | 6.6 | 145 | Citations (PDF) |
| 359 | Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention or after acute coronary syndrome | 1.3 | 1 | Citations (PDF) |
| 360 | PCSK9
Loss-of-Function Variants, Low-Density Lipoprotein Cholesterol, and Risk of Coronary Heart Disease and Stroke | 3.8 | 84 | Citations (PDF) |
| 361 | Monocyte gene expression in childhood obesity is associated with obesity and complexity of atherosclerosis in adults | 3.4 | 22 | Citations (PDF) |
| 362 | Accuracy and reproducibility of fast fractional flow reserve computation from invasive coronary angiography | 1.2 | 32 | Citations (PDF) |
| 363 | Relationship Between Coronary Contrast-Flow Quantitative Flow Ratio and Myocardial Ischemia Assessed by SPECT MPI | 5.5 | 19 | Citations (PDF) |
| 364 | Chronic use of low-dose aspirin is not associated with lower bone mineral density in the general population | 2.2 | 11 | Citations (PDF) |
| 365 | Association of metabolic syndrome and electrocardiographic markers of subclinical cardiovascular disease | 3.4 | 17 | Citations (PDF) |
| 366 | Genetic Risk Prediction of Atrial Fibrillation | 18.0 | 105 | Citations (PDF) |
| 367 | Very Long-Term Follow-Up After Coronary Rotational Atherectomy: A Single-Center Experience | 1.9 | 0 | Citations (PDF) |
| 368 | Guide extension catheter stepwise advancement facilitated by repeated distal balloon anchoring | 0.7 | 6 | Citations (PDF) |
| 369 | 5014Left ventricular global longitudinal strain is associated with all-cause mortality in a large cohort of patients with chronic kidney disease | 2.2 | 0 | Citations (PDF) |
| 370 | P4406The associations of overall and abdominal adiposity with ECG measures of subclinical cardiovascular disease in a middle-aged population | 2.2 | 0 | Citations (PDF) |
| 371 | Lower Performance in Orientation to Time and Place Associates with Greater Risk of Cardiovascular Events and Mortality in the Oldest Old: Leiden 85-Plus Study | 3.9 | 2 | Citations (PDF) |
| 372 | MDCO-216 Does Not Induce Adverse Immunostimulation, in Contrast to Its Predecessor ETC-216 | 2.1 | 46 | Citations (PDF) |
| 373 | P6121Prevalence of left ventricular systolic dysfunction in pre-dialysis and dialysis patients with preserved left ventricular ejection fraction | 2.2 | 2 | Citations (PDF) |
| 374 | Identification of a novel proinsulin-associated SNP and demonstration that proinsulin is unlikely to be a causal factor in subclinical vascular remodelling using Mendelian randomisation | 1.5 | 3 | Citations (PDF) |
| 375 | Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease | 25.2 | 257 | Citations (PDF) |
| 376 | Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity | 25.2 | 397 | Citations (PDF) |
| 377 | Impact of computed tomography myocardial perfusion following computed tomography coronary angiography on downstream referral for invasive coronary angiography, revascularization and, outcome at 12 months | 1.4 | 25 | Citations (PDF) |
| 378 | Body fat distribution, in particular visceral fat, is associated with cardiometabolic risk factors in obese women | 2.3 | 143 | Citations (PDF) |
| 379 | The epigenetic factor PCAF regulates vascular inflammation and is essential for intimal hyperplasia development | 2.3 | 44 | Citations (PDF) |
| 380 | Blood Pressure Lowering Medication, Visit-to-Visit Blood Pressure
Variability, and Cognitive Function in Old Age | 2.0 | 19 | Citations (PDF) |
| 381 | Platelet density per monocyte predicts adverse events in patients after percutaneous coronary intervention | 4.1 | 3 | Citations (PDF) |
| 382 | Genome-Wide Association Study for Incident Myocardial Infarction and Coronary Heart Disease in Prospective Cohort Studies: The CHARGE Consortium | 2.3 | 77 | Citations (PDF) |
| 383 | Visit-to-visit blood pressure variability and future functional decline in old age | 2.1 | 23 | Citations (PDF) |
| 384 | The multifaceted interplay between lipids and epigenetics | 4.0 | 11 | Citations (PDF) |
| 385 | Renal function estimation and Cockcroft–Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart ‘OMics’ in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives | 7.1 | 54 | Citations (PDF) |
| 386 | Meta-analysis of genome-wide association studies of HDL cholesterol response to statins | 3.8 | 35 | Citations (PDF) |
| 387 | Evaluating bococizumab, a monoclonal antibody to PCSK9, on lipid levels and clinical events in broad patient groups with and without prior cardiovascular events: Rationale and design of the Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Lipid Lowering and SPIRE Cardiovascular Outcomes Trials | 2.9 | 64 | Citations (PDF) |
| 388 | Vein graft failure: from pathophysiology to clinical outcomes | 35.5 | 278 | Citations (PDF) |
| 389 | Identification of additional risk loci for stroke and small vessel disease: a meta-analysis of genome-wide association studies | 17.9 | 157 | Citations (PDF) |
| 390 | Coding Variation in
ANGPTL4,
LPL,
and
SVEP1
and the Risk of Coronary Disease | 34.5 | 491 | Citations (PDF) |
| 391 | Genetic Evidence for a Link Between Favorable Adiposity and Lower Risk of Type 2 Diabetes, Hypertension, and Heart Disease | 4.2 | 148 | Citations (PDF) |
| 392 | Cystatin C and Cardiovascular Disease | 2.3 | 138 | Citations (PDF) |
| 393 | Thyroid Function Within the Reference Range and the Risk of Stroke: An Individual Participant Data Analysis | 4.0 | 87 | Citations (PDF) |
| 394 | Quaking post-transcriptionally promotes differentiation of monocytes into pro-atherogenic macrophages by controling pre-mRNA splicing and gene expression | 1.5 | 2 | Citations (PDF) |
| 395 | Affitope-based anti-PCSK9 (proprotein convertase subtilisin/kexin type 9) vaccine (AT04A) reduces atherosclerosis in APOE*3Leiden.CETP mice | 1.5 | 0 | Citations (PDF) |
| 396 | The role of inflammation in the association between adiposity and subclinical atherosclerosis | 1.5 | 0 | Citations (PDF) |
| 397 | Association of baseline apolipoprotein B and friedewald LDLC with long-term re-infarction in hypertriglyceridemic patients with ST-segment elevation myocardial infarction | 1.5 | 0 | Citations (PDF) |
| 398 | Novel genetic loci underlying human intracranial volume identified through genome-wide association | 17.1 | 240 | Citations (PDF) |
| 399 | Blood lipids influence DNA methylation in circulating cells | 8.1 | 177 | Citations (PDF) |
| 400 | The APOE*3Leiden.GK+/- mouse as novel translational model for dyslipidemia, type 2 diabetes and macrovascular complications | 1.5 | 1 | Citations (PDF) |
| 401 | Traditional and New Composite Endpoints in Heart Failure Clinical Trials: Facilitating Comprehensive Efficacy Assessments and Improving Trial Efficiency | 7.3 | 90 | Citations (PDF) |
| 402 | KLB
is associated with alcohol drinking, and its gene product β-Klotho is necessary for FGF21 regulation of alcohol preference | 7.5 | 245 | Citations (PDF) |
| 403 | Multiethnic Exome-Wide Association Study of Subclinical Atherosclerosis | 3.8 | 67 | Citations (PDF) |
| 404 | Rooted in Risk: Genetic Predisposition for Low-Density Lipoprotein Cholesterol Level Associates with Diminished Low-Density Lipoprotein Cholesterol Response to Statin Treatment | 1.5 | 11 | Citations (PDF) |
| 405 | 52 Genetic Loci Influencing Myocardial Mass | 2.3 | 132 | Citations (PDF) |
| 406 | Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension | 25.2 | 302 | Citations (PDF) |
| 407 | Higher Visit-to-Visit Low-Density Lipoprotein Cholesterol Variability Is Associated With Lower Cognitive Performance, Lower Cerebral Blood Flow, and Greater White Matter Hyperintensity Load in Older Subjects | 18.0 | 82 | Citations (PDF) |
| 408 | Gene-gene Interaction Analyses for Atrial Fibrillation | 3.4 | 16 | Citations (PDF) |
| 409 | A genomic approach to therapeutic target validation identifies a glucose-lowering
GLP1R
variant protective for coronary heart disease | 12.5 | 113 | Citations (PDF) |
| 410 | Quaking promotes monocyte differentiation into pro-atherogenic macrophages by controlling pre-mRNA splicing and gene expression | 13.7 | 104 | Citations (PDF) |
| 411 | Advantages and disadvantages of unstructured cardiovascular risk factor screening for follow-up in primary care | 2.0 | 0 | Citations (PDF) |
| 412 | Treatment variation in stent choice in patients with stable or unstable coronary artery disease | 1.3 | 4 | Citations (PDF) |
| 413 | HDL functionality in South Asians as compared to white Caucasians | 3.2 | 15 | Citations (PDF) |
| 414 | Opportunities for improvement in anti-thrombotic therapy and other strategies for the management of acute coronary syndromes: Insights from EPICOR, an international study of current practice patterns | 1.0 | 41 | Citations (PDF) |
| 415 | Value of Coronary Computed Tomography Angiography in Tailoring Aspirin Therapy for Primary Prevention of Atherosclerotic Events in Patients at High Risk With Diabetes Mellitus | 1.8 | 23 | Citations (PDF) |
| 416 | Association between Hepatic Triglyceride Content and Left Ventricular Diastolic Function in a Population-based Cohort: The Netherlands Epidemiology of Obesity Study | 8.7 | 19 | Citations (PDF) |
| 417 | Serum CETP concentration is not associated with measures of body fat: The NEO study | 1.5 | 9 | Citations (PDF) |
| 418 | Risk stratification and treatment effect of statins in secondary cardiovascular prevention in old age: Additive value of N-terminal pro-B-type natriuretic peptide | 2.0 | 7 | Citations (PDF) |
| 419 | 10-Second heart rate variability and cognitive function in old age | 1.0 | 75 | Citations (PDF) |
| 420 | Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function | 13.7 | 507 | Citations (PDF) |
| 421 | High-sensitivity cardiac troponin T is associated with cognitive decline in older adults at high cardiovascular risk | 2.0 | 27 | Citations (PDF) |
| 422 | Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries | 4.0 | 54 | Citations (PDF) |
| 423 | P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries | 4.0 | 50 | Citations (PDF) |
| 424 | A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration | 2.9 | 90 | Citations (PDF) |
| 425 | 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: comments from the Dutch ACS working group | 1.3 | 56 | Citations (PDF) |
| 426 | Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients | 2.8 | 29 | Citations (PDF) |
| 427 | Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure | 3.2 | 41 | Citations (PDF) |
| 428 | 4C.03 | 2.1 | 4 | Citations (PDF) |
| 429 | Fine mapping the CETP region reveals a common intronic insertion associated to HDL-C | 5.5 | 9 | Citations (PDF) |
| 430 | The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study | 3.2 | 402 | Citations (PDF) |
| 431 | Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease | 2.3 | 37 | Citations (PDF) |
| 432 | Drug-Gene Interactions of Antihypertensive Medications and Risk of Incident Cardiovascular Disease: A Pharmacogenomics Study from the CHARGE Consortium | 2.3 | 17 | Citations (PDF) |
| 433 | Candidate Gene Analysis of Mortality in Dialysis Patients | 2.3 | 7 | Citations (PDF) |
| 434 | Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes | 34.5 | 4,159 | Citations (PDF) |
| 435 | Biological Correlates of Blood Pressure Variability in Elderly at High Risk of Cardiovascular Disease | 2.0 | 12 | Citations (PDF) |
| 436 | Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raisingA systematic review and meta-analysis of relevant preclinical studies and clinical trials | 4.3 | 54 | Citations (PDF) |
| 437 | Associations Between Thrombin Generation and the Risk of Cardiovascular Disease in Elderly Patients: Results From the PROSPER Study | 3.4 | 35 | Citations (PDF) |
| 438 | Heavier smoking may lead to a relative increase in waist circumference: evidence for a causal relationship from a Mendelian randomisation meta-analysis. The CARTA consortium | 1.9 | 63 | Citations (PDF) |
| 439 | Overweight can be used as a tool to guide case-finding for cardiovascular risk assessment | 2.3 | 3 | Citations (PDF) |
| 440 | Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations: Table 1 | 4.0 | 13 | Citations (PDF) |
| 441 | Genetic studies of body mass index yield new insights for obesity biology | 37.9 | 4,533 | Citations (PDF) |
| 442 | Directional dominance on stature and cognition in diverse human populations | 37.9 | 199 | Citations (PDF) |
| 443 | Changes in ischaemia as assessed with single-photon emission computed tomography myocardial perfusion imaging in high-risk patients with diabetes without cardiac symptoms: relation with coronary atherosclerosis on computed tomography coronary angiography | 1.4 | 5 | Citations (PDF) |
| 444 | Association of Cardiometabolic Multimorbidity With Mortality | 16.5 | 991 | Citations (PDF) |
| 445 | Individual contributions of visceral fat and total body fat to subclinical atherosclerosis: The NEO study | 1.5 | 47 | Citations (PDF) |
| 446 | Subclinical Hypothyroidism and the Risk of Stroke Events and Fatal Stroke: An Individual Participant Data Analysis | 4.0 | 203 | Citations (PDF) |
| 447 | Heart rate variability, but not heart rate, is associated with handgrip strength and mortality in older Africans at very low cardiovascular risk: A population-based study | 2.2 | 26 | Citations (PDF) |
| 448 | LDL cholesterol still a problem in old age? A Mendelian randomization study | 4.9 | 48 | Citations (PDF) |
| 449 | Multiethnic Genome-Wide Association Study of Cerebral White Matter Hyperintensities on MRI | 3.8 | 186 | Citations (PDF) |
| 450 | Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin | 2.2 | 74 | Citations (PDF) |
| 451 | Blood Leukocyte Count on Admission Predicts Cardiovascular Events in Patients with Acute Non-ST Elevation Myocardial Infarction | 1.0 | 9 | Citations (PDF) |
| 452 | Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation | 25.2 | 342 | Citations (PDF) |
| 453 | Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9 | 3.6 | 31 | Citations (PDF) |
| 454 | Research ethics needs fine tuning, not rigidity: how to promote evidence in neglected patient populations by rethinking informed consent: Figure 1 | 2.2 | 4 | Citations (PDF) |
| 455 | Ticagrelor or prasugrel versus clopidogrel in elderly patients with an acute coronary syndrome: Optimization of antiplatelet treatment in patients 70 years and older—rationale and design of the POPular AGE study | 2.9 | 46 | Citations (PDF) |
| 456 | Effect of Smoking on Blood Pressure and Resting Heart Rate | 3.8 | 138 | Citations (PDF) |
| 457 | Association between changes in brain microstructure and cognition in older subjects at increased risk for vascular disease | 1.9 | 6 | Citations (PDF) |
| 458 | White Matter Lesion Progression | 5.9 | 29 | Citations (PDF) |
| 459 | Genome of the Netherlands population-specific imputations identify an ABCA6 variant associated with cholesterol levels | 13.7 | 51 | Citations (PDF) |
| 460 | Resting heart rate, heart rate variability and functional decline in old ageCmaj, 2015, 187, E442-E449 | 1.2 | 73 | Citations (PDF) |
| 461 | Executive function, but not memory, associates with incident coronary heart disease and stroke | 1.0 | 35 | Citations (PDF) |
| 462 | A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease | 25.2 | 2,524 | Citations (PDF) |
| 463 | Contemporary inter-hospital transfer patterns for the management of acute coronary syndrome patients: Findings from the EPICOR study | 1.0 | 14 | Citations (PDF) |
| 464 | The role of insulin resistance in the association between body fat and autonomic function | 3.2 | 30 | Citations (PDF) |
| 465 | HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials | 62.1 | 651 | Citations (PDF) |
| 466 | Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studies | 2.0 | 29 | Citations (PDF) |
| 467 | Genome-wide association studies identify genetic loci for low von Willebrand factor levels | 3.0 | 57 | Citations (PDF) |
| 468 | Prognostic value of coronary computed tomography angiography in diabetic patients without chest pain syndrome | 1.8 | 19 | Citations (PDF) |
| 469 | Increased Platelet Reactivity Is Associated with Circulating Platelet-Monocyte Complexes and Macrophages in Human Atherosclerotic Plaques | 2.3 | 9 | Citations (PDF) |
| 470 | No Evidence for Genome-Wide Interactions on Plasma Fibrinogen by Smoking, Alcohol Consumption and Body Mass Index: Results from Meta-Analyses of 80,607 Subjects | 2.3 | 9 | Citations (PDF) |
| 471 | Polygenic Overlap Between Kidney Function and Large Artery Atherosclerotic Stroke | 5.9 | 23 | Citations (PDF) |
| 472 | Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins | 13.7 | 253 | Citations (PDF) |
| 473 | A genome-wide copy number association study of osteoporotic fractures points to the 6p25.1 locus | 3.8 | 38 | Citations (PDF) |
| 474 | Stratification by Smoking Status Reveals an Association of CHRNA5-A3-B4 Genotype with Body Mass Index in Never Smokers | 3.2 | 54 | Citations (PDF) |
| 475 | Genome-Wide Association Study for Circulating Tissue Plasminogen Activator Levels and Functional Follow-Up Implicates Endothelial
STXBP5
and
STX2 | 6.0 | 47 | Citations (PDF) |
| 476 | Very-Low-Calorie Diet Increases Myocardial Triglyceride Content and Decreases Diastolic Left Ventricular Function in Type 2 Diabetes With Cardiac Complications | 6.2 | 17 | Citations (PDF) |
| 477 | Antiplatelet therapy in acute coronary syndrome: current status and future directions | 0.1 | 0 | Citations (PDF) |
| 478 | Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome | 16.5 | 328 | Citations (PDF) |
| 479 | Impact of Timing of Eptifibatide Administration on Preprocedural Infarct-Related Artery Patency in Acute STEMI Patients Undergoing Primary PCI | 1.0 | 1 | Citations (PDF) |
| 480 | A Randomized Comparison between Everolimus-Eluting Stent and Cobalt Chromium Stent in Patients with Acute ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Using Routine Intravenous Eptifibatide: The X-MAN (Xience vs. Multi-Link Stent in Acute Myocardial Infarction) Trial, A Pilot Study | 1.0 | 1 | Citations (PDF) |
| 481 | N‐terminal pro–brain natriuretic peptide and cognitive decline in older adults at high cardiovascular risk | 6.6 | 21 | Citations (PDF) |
| 482 | Homocysteine Levels and Treatment Effect in the Prospective Study of Pravastatin in the Elderly at Risk | 2.9 | 26 | Citations (PDF) |
| 483 | Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity | 0.6 | 93 | Citations (PDF) |
| 484 | Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial | 2.9 | 385 | Citations (PDF) |
| 485 | Glycated Hemoglobin Measurement and Prediction of Cardiovascular Disease | 16.5 | 203 | Citations (PDF) |
| 486 | Comparing a marginal structural model with a Cox proportional hazard model to estimate the effect of time-dependent drug use in observational studies: statin use for primary prevention of cardiovascular disease as an example from the Rotterdam Study | 5.3 | 20 | Citations (PDF) |
| 487 | Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patients | 2.1 | 43 | Citations (PDF) |
| 488 | Leukocyte telomere length associates with prospective mortality independent of immune-related parameters and known genetic markers | 4.9 | 99 | Citations (PDF) |
| 489 | Differential Complement Activation Pathways Promote C3b Deposition on Native and Acetylated LDL thereby Inducing Lipoprotein Binding to the Complement Receptor 1 | 2.2 | 19 | Citations (PDF) |
| 490 | ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment | 1.5 | 16 | Citations (PDF) |
| 491 | TROPONIN T IS A STRONG MARKER FOR CARDIOVASCULAR DISEASE IN DIALYSIS PATIENTS, DESPITE HIGH BACKGROUND LEVELS OF SERUM TROPONIN T | 2.3 | 0 | Citations (PDF) |
| 492 | A metabolomic profile is associated with the risk of incident coronary heart disease | 2.9 | 80 | Citations (PDF) |
| 493 | Brown adipose tissue volume in healthy lean south Asian adults compared with white Caucasians: a prospective, case-controlled observational study | 21.7 | 145 | Citations (PDF) |
| 494 | Novel Genetic Markers Associate With Atrial Fibrillation Risk in Europeans and Japanese | 2.3 | 143 | Citations (PDF) |
| 495 | Vitamin D3 mediated effects on postprandial leukocyte activation and arterial stiffness in men and women | 2.5 | 11 | Citations (PDF) |
| 496 | Chronic Kidney Disease and Implantable Cardioverter Defibrillator Related Complications: 16 Years of Experience | 2.1 | 24 | Citations (PDF) |
| 497 | Contrasting associations of insulin resistance with diabetes, cardiovascular disease and all-cause mortality in the elderly: PROSPER long-term follow-up | 7.5 | 38 | Citations (PDF) |
| 498 | Body fat, especially visceral fat, is associated with electrocardiographic measures of sympathetic activation | 4.0 | 38 | Citations (PDF) |
| 499 | PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE | 3.6 | 75 | Citations (PDF) |
| 500 | Subclinical Thyroid Dysfunction and Functional Capacity Among Elderly | 4.4 | 40 | Citations (PDF) |
| 501 | Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin | 3.6 | 193 | Citations (PDF) |
| 502 | Integrating Genetic, Transcriptional, and Functional Analyses to Identify 5 Novel Genes for Atrial Fibrillation | 18.0 | 208 | Citations (PDF) |
| 503 | Annotation of loci from genome-wide association studies using tissue-specific quantitative interaction proteomics | 24.6 | 77 | Citations (PDF) |
| 504 | Genome-wide association meta-analysis of human longevity identifies a novel locus conferring survival beyond 90 years of age | 2.9 | 262 | Citations (PDF) |
| 505 | Scarcity of atrial fibrillation in a traditional African population: a community-based study | 2.0 | 24 | Citations (PDF) |
| 506 | Defining the role of common variation in the genomic and biological architecture of adult human height | 25.2 | 1,982 | Citations (PDF) |
| 507 | Associations of atherosclerosis in the descending thoracic aorta on CTA with arterial stiffness and chronic kidney disease in asymptomatic patients with diabetes mellitus | 1.2 | 9 | Citations (PDF) |
| 508 | Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data | 0.2 | 602 | Citations (PDF) |
| 509 | The dialysis procedure as a trigger for atrial fibrillation: new insights in the development of atrial fibrillation in dialysis patientsHeart, 2014, 100, 685-690 | 3.9 | 116 | Citations (PDF) |
| 510 | In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER study | 1.5 | 11 | Citations (PDF) |
| 511 | Comparison by Computed Tomographic Angiography—The Presence and Extent of Coronary Arterial Atherosclerosis in South Asians Versus Caucasians With Diabetes Mellitus | 1.8 | 30 | Citations (PDF) |
| 512 | Alirocumab, monoclonal antibody to PCSK9, dose-dependently decreases atherosclerosis, improves plaque stability and shows additive effects with atorvastatin in apoe*3leiden.cetp mice | 1.5 | 1 | Citations (PDF) |
| 513 | Temporal Trends of System of Care for STEMI: Insights from the Jakarta Cardiovascular Care Unit Network System | 2.3 | 15 | Citations (PDF) |
| 514 | Different value of coronary calcium score to predict obstructive coronary artery disease in patients with and without moderate chronic kidney disease | 1.3 | 17 | Citations (PDF) |
| 515 | Long Term Effects of Epoetin Alfa in Patients with ST- Elevation Myocardial Infarction | 2.1 | 12 | Citations (PDF) |
| 516 | Automatic quantification and characterization of coronary atherosclerosis with computed tomography coronary angiography: cross-correlation with intravascular ultrasound virtual histology | 1.2 | 225 | Citations (PDF) |
| 517 | Association of atherosclerosis in the descending thoracic aorta with coronary artery disease on multi detector row computed tomography coronary angiography in patients with suspected coronary artery disease | 1.2 | 13 | Citations (PDF) |
| 518 | Circulating cells as predictors of secondary manifestations of cardiovascular disease: design of the CIRCULATING CELLS study | 2.8 | 23 | Citations (PDF) |
| 519 | Secretory Phospholipase A2-IIA and Cardiovascular Disease | 2.3 | 122 | Citations (PDF) |
| 520 | An Unexpected Intriguing Effect of Toll-Like Receptor Regulator RP105 (CD180) on Atherosclerosis Formation With Alterations on B-Cell Activation | 6.0 | 25 | Citations (PDF) |
| 521 | Abdominal adiposity largely explains associations between insulin resistance, hyperglycemia and subclinical atherosclerosis: The NEO study | 1.5 | 37 | Citations (PDF) |
| 522 | Identification and systematic annotation of tissue-specific differentially methylated regions using the Illumina 450k array | 3.2 | 213 | Citations (PDF) |
| 523 | The Netherlands Epidemiology of Obesity (NEO) study: study design and data collection | 5.3 | 191 | Citations (PDF) |
| 524 | Resting Heart Rate and Incident Heart Failure and Cardiovascular Mortality in Older Adults: Role of Inflammation and Endothelial Dysfunction: The PROSPER Study | 7.3 | 66 | Citations (PDF) |
| 525 | Common Variants in Mendelian Kidney Disease Genes and Their Association with Renal Function | 0.4 | 36 | Citations (PDF) |
| 526 | Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction | 2.2 | 30 | Citations (PDF) |
| 527 | T-cell co-stimulation by CD28–CD80/86 and its negative regulator CTLA-4 strongly influence accelerated atherosclerosis development | 2.2 | 128 | Citations (PDF) |
| 528 | Increased cytokine response after toll-like receptor stimulation in patients with stable coronary artery disease | 1.5 | 20 | Citations (PDF) |
| 529 | Influence of Gender on Ischemic Times and Outcomes After ST-Elevation Myocardial Infarction | 1.8 | 60 | Citations (PDF) |
| 530 | Outcome After ST Elevation Myocardial Infarction in Patients With Cancer Treated With Primary Percutaneous Coronary Intervention | 1.8 | 115 | Citations (PDF) |
| 531 | High coronary plaque load: a heavy burden | 2.2 | 6 | Citations (PDF) |
| 532 | Stratified Patient-Centered Care in Type 2 Diabetes | 6.2 | 35 | Citations (PDF) |
| 533 | Quaking, an RNA-Binding Protein, Is a Critical Regulator of Vascular Smooth Muscle Cell Phenotype | 13.1 | 108 | Citations (PDF) |
| 534 | Temporal trends of system of care for STEMI: insights from the jakarta cardiovascular care unit network system | 2.2 | 1 | Citations (PDF) |
| 535 | Incremental prognostic value of an abnormal baseline spatial QRS-T angle in chronic dialysis patients | 2.0 | 43 | Citations (PDF) |
| 536 | Echocardiographical determinants of an abnormal spatial QRS-T angle in chronic dialysis patients | 0.8 | 6 | Citations (PDF) |
| 537 | No genetic determinants of differential cardiovascular event reduction by pravastatin in the PROSPER/PHASE study | 2.2 | 0 | Citations (PDF) |
| 538 | Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose–response meta-regression | 2.0 | 464 | Citations (PDF) |
| 539 | The Use of Intra-aortic Balloon Pump in a Real-World Setting: A Comparison between Survivors and Nonsurvivors from Acute Coronary Syndrome Treated with IABP. The Jakarta Acute Coronary Syndrome Registry | 1.0 | 6 | Citations (PDF) |
| 540 | Total cerebral blood flow and mortality in old age | 1.0 | 27 | Citations (PDF) |
| 541 | Association of visit-to-visit variability in blood pressure with cognitive function in old age: prospective cohort study | 0.2 | 146 | Citations (PDF) |
| 542 | A Meta-Analysis of Thyroid-Related Traits Reveals Novel Loci and Gender-Specific Differences in the Regulation of Thyroid Function | 3.2 | 216 | Citations (PDF) |
| 543 | PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population | 3.6 | 58 | Citations (PDF) |
| 544 | Stabilization of atherosclerotic plaques: an update | 2.2 | 118 | Citations (PDF) |
| 545 | Circulating interleukin‐6 concentration and cognitive decline in old age: the PROSPER study | 7.3 | 111 | Citations (PDF) |
| 546 | Non-invasive assessment of microcirculation by sidestream dark field imaging as a marker of coronary artery disease in diabetes | 2.7 | 30 | Citations (PDF) |
| 547 | Lysine Acetyltransferase PCAF Is a Key Regulator of Arteriogenesis | 6.0 | 59 | Citations (PDF) |
| 548 | Multiethnic Meta-Analysis of Genome-Wide Association Studies in >100 000 Subjects Identifies 23 Fibrinogen-Associated Loci but No Strong Evidence of a Causal Association Between Circulating Fibrinogen and Cardiovascular Disease | 18.0 | 142 | Citations (PDF) |
| 549 | Journey Through Cholesteryl Ester Transfer Protein Inhibition | 4.1 | 11 | Citations (PDF) |
| 550 | Thrombus management in the catheterisation laboratory in the setting of primary percutaneous coronary intervention: what is the current evidence? | 3.9 | 5 | Citations (PDF) |
| 551 | Candidate Gene Analysis of Arteriovenous Fistula Failure in Hemodialysis Patients | 4.2 | 14 | Citations (PDF) |
| 552 | Visceral fat is stronger associated with electrocardiographic measures of sympathetic activation than subcutaneous fat in individuals with structurally normal hearts: the NEO study | 2.2 | 0 | Citations (PDF) |
| 553 | The ABCA1 gene variant and heart disease risk reduction in the elderly during pravastatin treatment | 2.2 | 0 | Citations (PDF) |
| 554 | RP105 (cd180) as a TLR-4 regulator ameliorates atherosclerosis via its role on B-cells | 2.2 | 1 | Citations (PDF) |
| 555 | PCSK9 SNP rs11591147 is associated with low cholesterol levels but not with cognitive performance or noncardiovascular clinical events in an elderly population | 3.6 | 24 | Citations (PDF) |
| 556 | Non-Homologous End-Joining Pathway Associated with Occurrence of Myocardial Infarction: Gene Set Analysis of Genome-Wide Association Study Data | 2.3 | 18 | Citations (PDF) |
| 557 | Subclinical Thyroid Dysfunction and Cognitive Decline in Old Age | 2.3 | 57 | Citations (PDF) |
| 558 | Long-Term Effects of Statin Treatment in Elderly People: Extended Follow-Up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) | 2.3 | 47 | Citations (PDF) |
| 559 | BMP7 Activates Brown Adipose Tissue and Reduces Diet-Induced Obesity Only at Subthermoneutrality | 2.3 | 96 | Citations (PDF) |
| 560 | Erythrocyte-Bound Apolipoprotein B in Relation to Atherosclerosis, Serum Lipids and ABO Blood Group | 2.3 | 27 | Citations (PDF) |
| 561 | Drug–gene interactions and the search for missing heritability: a cross-sectional pharmacogenomics study of the QT interval | 2.6 | 29 | Citations (PDF) |
| 562 | Toll-Like Receptor Induced CD11b and L-Selectin Response in Patients with Coronary Artery Disease | 2.3 | 4 | Citations (PDF) |
| 563 | Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol | 2.3 | 37 | Citations (PDF) |
| 564 | TLR Accessory Molecule RP105 (CD180) Is Involved in Post-Interventional Vascular Remodeling and Soluble RP105 Modulates Neointima Formation | 2.3 | 23 | Citations (PDF) |
| 565 | CT Coronary Angiography Is Feasible for the Assessment of Coronary Artery Disease in Chronic Dialysis Patients, Despite High Average Calcium Scores | 2.3 | 26 | Citations (PDF) |
| 566 | Pathway Analysis Using Genome-Wide Association Study Data for Coronary Restenosis – A Potential Role for the PARVB Gene | 2.3 | 12 | Citations (PDF) |
| 567 | Subclinical Thyroid Dysfunction and the Risk of Heart Failure in Older Persons at High Cardiovascular Risk | 4.0 | 195 | Citations (PDF) |
| 568 | Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial | 2.2 | 217 | Citations (PDF) |
| 569 | Human ATP–Binding Cassette G1 Controls Macrophage Lipoprotein Lipase Bioavailability and Promotes Foam Cell Formation | 6.0 | 43 | Citations (PDF) |
| 570 | Republished: How to reduce sudden cardiac death in patients with renal failure | 1.6 | 0 | Citations (PDF) |
| 571 | Genome-Wide Association and Functional Follow-Up Reveals New Loci for Kidney Function | 3.2 | 184 | Citations (PDF) |
| 572 | Integration of genome-wide association studies with biological knowledge identifies six novel genes related to kidney function | 2.9 | 66 | Citations (PDF) |
| 573 | Literature-Based Genetic Risk Scores for Coronary Heart Disease | 3.8 | 55 | Citations (PDF) |
| 574 | Lipid-Related Markers and Cardiovascular Disease Prediction | 16.5 | 389 | Citations (PDF) |
| 575 | Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a) | 3.6 | 116 | Citations (PDF) |
| 576 | Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways | 25.2 | 808 | Citations (PDF) |
| 577 | How to reduce sudden cardiac death in patients with renal failure | 3.9 | 8 | Citations (PDF) |
| 578 | Blocking Toll-Like Receptors 7 and 9 Reduces Postinterventional Remodeling via Reduced Macrophage Activation, Foam Cell Formation, and Migration | 6.0 | 43 | Citations (PDF) |
| 579 | Hypermethylation at loci sensitive to the prenatal environment is associated with increased incidence of myocardial infarction | 4.9 | 77 | Citations (PDF) |
| 580 | Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) | 2.3 | 72 | Citations (PDF) |
| 581 | Will the interplay between genetic markers for risk factors for a disease and the disease itself bring genetics closer to clinical practice? Great expectations | 2.2 | 0 | Citations (PDF) |
| 582 | Automated quantification of coronary plaque with computed tomography: comparison with intravascular ultrasound using a dedicated registration algorithm for fusion-based quantification | 2.2 | 224 | Citations (PDF) |
| 583 | Prognostic value of coronary vessel dominance in relation to significant coronary artery disease determined with non-invasive computed tomography coronary angiography | 2.2 | 63 | Citations (PDF) |
| 584 | Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin | 2.1 | 29 | Citations (PDF) |
| 585 | The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis | 62.1 | 1,098 | Citations (PDF) |
| 586 | Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes | 34.5 | 737 | Citations (PDF) |
| 587 | Late acquired stent malapposition: why, when and how to handle?Heart, 2012, 98, 1529-1536 | 3.9 | 27 | Citations (PDF) |
| 588 | Republished article: Pharmacogenetics of antiplatelet therapy: ready for clinical application? | 1.6 | 0 | Citations (PDF) |
| 589 | The Controversies of Statin Therapy | 2.3 | 149 | Citations (PDF) |
| 590 | Genetic variation at the SLCO1B1 gene locus and low density lipoprotein cholesterol lowering response to pravastatin in the elderly | 1.5 | 31 | Citations (PDF) |
| 591 | KIF6, LPA, TAS2R50, and VAMP8 genetic variation, low density lipoprotein cholesterol lowering response to pravastatin, and heart disease risk reduction in the elderly | 1.5 | 29 | Citations (PDF) |
| 592 | Annexin A5 prevents post-interventional accelerated atherosclerosis development in a dose-dependent fashion in mice | 1.5 | 25 | Citations (PDF) |
| 593 | A comparison of non-HDL and LDL cholesterol goal attainment in a large, multinational patient population: The Lipid Treatment Assessment Project 2 | 1.5 | 37 | Citations (PDF) |
| 594 | Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture | 25.2 | 1,207 | Citations (PDF) |
| 595 | Age- and gender-specific differences in the prognostic value of CT coronary angiography | 3.9 | 24 | Citations (PDF) |
| 596 | Genetic variation in galectin-3 gene associates with cognitive function at old age | 3.4 | 33 | Citations (PDF) |
| 597 | Bramwell-Hill modeling for local aortic pulse wave velocity estimation: a validation study with velocity-encoded cardiovascular magnetic resonance and invasive pressure assessment | 4.3 | 63 | Citations (PDF) |
| 598 | Epigenetic control of CCR5 transcript levels in immune cells and modulation by small molecules inhibitors | 4.0 | 25 | Citations (PDF) |
| 599 | Evolving strategies in the management of acute coronary syndromes with oral antiplatelet agents | 0.2 | 4 | Citations (PDF) |
| 600 | The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity | 2.3 | 32 | Citations (PDF) |
| 601 | Cardiovascular Metabolic Syndrome: Mediators Involved in the Pathophysiology from Obesity to Coronary Heart Disease | 1.5 | 29 | Citations (PDF) |
| 602 | Potential cardiovascular consequences of switching from atorvastatin to generic simvastatin in the Netherlands | 1.3 | 7 | Citations (PDF) |
| 603 | Acute myocardial infarction system of care in the third world | 1.3 | 28 | Citations (PDF) |
| 604 | Fractional Flow Reserve Is Not Associated with Inflammatory Markers in Patients with Stable Coronary Artery Disease | 2.3 | 5 | Citations (PDF) |
| 605 | Plaque Rupture Complications in Murine Atherosclerotic Vein Grafts Can Be Prevented by TIMP-1 Overexpression | 2.3 | 48 | Citations (PDF) |
| 606 | A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance | 25.2 | 835 | Citations (PDF) |
| 607 | Pharmacogenetics of Statins: Achievements, Whole-genome Analyses and Future Perspectives | 1.5 | 39 | Citations (PDF) |
| 608 | A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application? | 2.2 | 69 | Citations (PDF) |
| 609 | Subclinical Thyroid Dysfunction and the Risk of Heart Failure Events | 18.0 | 480 | Citations (PDF) |
| 610 | Future Potential Biomarkers for Postinterventional Restenosis and Accelerated Atherosclerosis | 1.5 | 2 | Citations (PDF) |
| 611 | Aspiration Thrombectomy During Primary Percutaneous Coronary Intervention as Adjunctive Therapy to Early (in‐ambulance) Abciximab Administration in Patients with Acute ST Elevation Myocardial Infarction: An Analysis from Leiden MISSION! Acute Myocardial Infarction Treatment Optimization Program | 1.3 | 6 | Citations (PDF) |
| 612 | Comparison of Lipid Profiles and Attainment of Lipid Goals in Patients <65 Years Versus Patients ≥65 Years (from the Lipid Treatment Assessment Project [L-TAP] 2) | 1.8 | 7 | Citations (PDF) |
| 613 | Management of acute coronary syndrome: achievements and goals still to pursue. Novel developments in diagnosis and treatment | 7.3 | 21 | Citations (PDF) |
| 614 | The maximum necrotic core area is most often located proximally to the site of most severe narrowing: a virtual histology intravascular ultrasound study | 1.2 | 15 | Citations (PDF) |
| 615 | Non-invasive computed tomography coronary angiography as a gatekeeper for invasive coronary angiography | 1.2 | 16 | Citations (PDF) |
| 616 | Relationship between left ventricular diastolic function and arterial stiffness in asymptomatic patients with diabetes mellitus | 1.2 | 21 | Citations (PDF) |
| 617 | Added value of pharmacogenetic testing in predicting statin response: results from the REGRESS trial | 2.6 | 8 | Citations (PDF) |
| 618 | Genome-Wide Study of Gene Variants Associated with Differential Cardiovascular Event Reduction by Pravastatin Therapy | 2.3 | 33 | Citations (PDF) |
| 619 | Systematic Testing of Literature Reported Genetic Variation Associated with Coronary Restenosis: Results of the GENDER Study | 2.3 | 23 | Citations (PDF) |
| 620 | Risk of Cardiovascular Disease in a Traditional African Population with a High Infectious Load: A Population-Based Study | 2.3 | 56 | Citations (PDF) |
| 621 | Pre-infarction angina predicts thrombus burden in patients admitted for ST-segment elevation myocardial infarction | 3.0 | 23 | Citations (PDF) |
| 622 | Five-year clinical follow-up from the MISSION! Intervention Study: sirolimus-eluting stent versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction, a randomised controlled trial | 3.0 | 31 | Citations (PDF) |
| 623 | How to reduce the incidence of contrast induced acute kidney injury after cardiac (invasive) procedures, a review and practical recommendations | 2.1 | 8 | Citations (PDF) |
| 624 | RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome | 2.2 | 171 | Citations (PDF) |
| 625 | Subclinical left ventricular dysfunction and coronary atherosclerosis in asymptomatic patients with type 2 diabetes | 2.1 | 20 | Citations (PDF) |
| 626 | Inflammatory biomarkers, physical activity, waist circumference, and risk of future coronary heart disease in healthy men and women | 2.2 | 98 | Citations (PDF) |
| 627 | Initial stress in biomechanical models of atherosclerotic plaques | 2.2 | 50 | Citations (PDF) |
| 628 | Variation in the CBP gene involved in epigenetic control associates with cognitive function | 3.4 | 6 | Citations (PDF) |
| 629 | Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels | 1.5 | 47 | Citations (PDF) |
| 630 | Mannose binding lectin 2 haplotypes do not affect the progression of coronary atherosclerosis in men with proven coronary artery disease treated with pravastatin | 1.5 | 7 | Citations (PDF) |
| 631 | ABCA1 impacts athero-thrombotic risk and 10-year survival in a contemporary secondary prevention setting | 1.5 | 12 | Citations (PDF) |
| 632 | Stabilisation of atherosclerotic plaques | 4.1 | 142 | Citations (PDF) |
| 633 | Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease | 25.2 | 1,836 | Citations (PDF) |
| 634 | Reaching C-Reactive Protein and Low-Density Lipoprotein Cholesterol Goals in Dyslipidemic Patients (from the Lipid Treatment Assessment Project [L-TAP] 2) | 1.8 | 8 | Citations (PDF) |
| 635 | Positive Remodeling on Coronary Computed Tomography as a Marker for Plaque Vulnerability on Virtual Histology Intravascular Ultrasound | 1.8 | 79 | Citations (PDF) |
| 636 | Comparison of the Relation Between the Calcium Score and Plaque Characteristics in Patients With Acute Coronary Syndrome Versus Patients With Stable Coronary Artery Disease, Assessed by Computed Tomography Angiography and Virtual Histology Intravascular Ultrasound | 1.8 | 39 | Citations (PDF) |
| 637 | Prognostic Value of Renal Dysfunction for the Prediction of Outcome Versus Results of Computed Tomographic Coronary Angiography | 1.8 | 15 | Citations (PDF) |
| 638 | Economic evaluation of ezetimibe combined with simvastatin for the treatment of primary hypercholesterolaemia | 1.3 | 15 | Citations (PDF) |
| 639 | Diagnostic performance of 320-slice multidetector computed tomography coronary angiography in patients after coronary artery bypass grafting | 3.6 | 58 | Citations (PDF) |
| 640 | Relationship between vascular stiffness and stress myocardial perfusion imaging in asymptomatic patients with diabetes | 5.5 | 10 | Citations (PDF) |
| 641 | Comprehensive assessment of spotty calcifications on computed tomography angiography: Comparison to plaque characteristics on intravascular ultrasound with radiofrequency backscatter analysis | 1.8 | 106 | Citations (PDF) |
| 642 | Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) | 3.3 | 18 | Citations (PDF) |
| 643 | Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses | 1.8 | 36 | Citations (PDF) |
| 644 | Clinical value of myocardial perfusion scintigraphy as a screening tool in liver transplant candidates | 2.5 | 17 | Citations (PDF) |
| 645 | A genome-wide association study identifies a region at chromosome 12 as a potential susceptibility locus for restenosis after percutaneous coronary intervention | 2.9 | 14 | Citations (PDF) |
| 646 | Toll-Like Receptor 4 Is Involved in Human and Mouse Vein Graft Remodeling, and Local Gene Silencing Reduces Vein Graft Disease in Hypercholesterolemic APOE*3Leiden Mice | 6.0 | 41 | Citations (PDF) |
| 647 | Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: evidence for a new concept from three independent prospective studies | 3.9 | 19 | Citations (PDF) |
| 648 | Annexin A5 Therapy Attenuates Vascular Inflammation and Remodeling and Improves Endothelial Function in Mice | 6.0 | 84 | Citations (PDF) |
| 649 | Circulating Interleukin-10 and Risk of Cardiovascular Events | 6.0 | 92 | Citations (PDF) |
| 650 | Cerebral Microbleeds Are Predictive of Mortality in the Elderly | 5.9 | 120 | Citations (PDF) |
| 651 | Diagnostic performance of non-invasive multidetector computed tomography coronary angiography to detect coronary artery disease using different endpoints: detection of significant stenosis vs. detection of atherosclerosis | 2.2 | 50 | Citations (PDF) |
| 652 | Influence of smoking on the prognostic value of cardiovascular computed tomography coronary angiography | 2.2 | 14 | Citations (PDF) |
| 653 | The incidence and risk factors for new onset atrial fibrillation in the PROSPER study | 2.0 | 59 | Citations (PDF) |
| 654 | Genetic Predictors of Fibrin D-Dimer Levels in Healthy Adults | 18.0 | 68 | Citations (PDF) |
| 655 | Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure | 25.2 | 424 | Citations (PDF) |
| 656 | Pharmacogenetics of antiplatelet therapy: ready for clinical application?Heart, 2011, 97, 1268-1276 | 3.9 | 7 | Citations (PDF) |
| 657 | Rationale and design of dal-VESSEL: a study to assess the safety and efficacy of dalcetrapib on endothelial function using brachial artery flow-mediated vasodilatation | 2.1 | 32 | Citations (PDF) |
| 658 | Restenosis after PCI. Part 1: pathophysiology and risk factors | 35.5 | 269 | Citations (PDF) |
| 659 | Restenosis after PCI. Part 2: prevention and therapy | 35.5 | 78 | Citations (PDF) |
| 660 | Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin | 2.6 | 180 | Citations (PDF) |
| 661 | Performance and efficacy of 320-row computed tomography coronary angiography in patients presenting with acute chest pain: results from a clinical registry | 1.2 | 28 | Citations (PDF) |
| 662 | Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary intervention | 1.2 | 10 | Citations (PDF) |
| 663 | Diagnostic Accuracy of 320-Row Multidetector Computed Tomography Coronary Angiography to Noninvasively Assess In-Stent Restenosis | 6.8 | 95 | Citations (PDF) |
| 664 | Standardised pre-hospital care of acute myocardial infarction patients: MISSION! guidelines applied in practice | 1.3 | 18 | Citations (PDF) |
| 665 | Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention | 3.7 | 25 | Citations (PDF) |
| 666 | Incremental prognostic value of left ventricular function analysis over non-invasive coronary angiography with multidetector computed tomography | 1.8 | 10 | Citations (PDF) |
| 667 | Diagnostic Accuracy of 64-Slice Multislice Computed Tomographic Coronary Angiography in Patients With an Intermediate Pretest Likelihood for Coronary Artery Disease | 1.8 | 19 | Citations (PDF) |
| 668 | Assessment With Multi-Slice Computed Tomography and Gray-Scale and Virtual Histology Intravascular Ultrasound of Gender-Specific Differences in Extent and Composition of Coronary Atherosclerotic Plaques in Relation to Age | 1.8 | 37 | Citations (PDF) |
| 669 | Evaluation of Contraindications and Efficacy of Oral Beta Blockade Before Computed Tomographic Coronary Angiography | 1.8 | 42 | Citations (PDF) |
| 670 | Three-Year Outcome of Sirolimus-Eluting Versus Bare-Metal Stents for the Treatment of ST-Segment Elevation Myocardial Infarction (from the MISSION! Intervention Study) | 1.8 | 47 | Citations (PDF) |
| 671 | Impact of Clinical Presentation and Pretest Likelihood on the Relation Between Calcium Score and Computed Tomographic Coronary Angiography | 1.8 | 42 | Citations (PDF) |
| 672 | Usefulness of Hypertriglyceridemic Waist Phenotype in Type 2 Diabetes Mellitus to Predict the Presence of Coronary Artery Disease as Assessed by Computed Tomographic Coronary Angiography | 1.8 | 42 | Citations (PDF) |
| 673 | Epigenetics in atherosclerosis and inflammation | 4.0 | 153 | Citations (PDF) |
| 674 | Improved aortic pulse wave velocity assessment from multislice two‐directional in‐plane velocity‐encoded magnetic resonance imaging | 3.4 | 47 | Citations (PDF) |
| 675 | Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction | 25.2 | 181 | Citations (PDF) |
| 676 | Statins and All-Cause Mortality in High-Risk Primary Prevention | 8.1 | 409 | Citations (PDF) |
| 677 | Combined non-invasive anatomical and functional assessment with MSCT and MRI for the detection of significant coronary artery disease in patients with an intermediate pre-test likelihood | 3.9 | 27 | Citations (PDF) |
| 678 | Genetic Variation at the
Phospholipid Transfer Protein
Locus Affects Its Activity and High-Density Lipoprotein Size and Is a Novel Marker of Cardiovascular Disease Susceptibility | 18.0 | 91 | Citations (PDF) |
| 679 | A single dose of erythropoietin in ST-elevation myocardial infarction | 2.2 | 145 | Citations (PDF) |
| 680 | Predictive Value of Multislice Computed Tomography Variables of Atherosclerosis for Ischemia on Stress-Rest Single-Photon Emission Computed Tomography | 2.9 | 18 | Citations (PDF) |
| 681 | Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly | 3.6 | 50 | Citations (PDF) |
| 682 | Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trial | 3.6 | 50 | Citations (PDF) |
| 683 | Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parameters | 2.1 | 26 | Citations (PDF) |
| 684 | A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease | 5.5 | 19 | Citations (PDF) |
| 685 | Increased Carotid Intima-Media Thickness as a Predictor of the Presence and Extent of Abnormal Myocardial Perfusion in Type 2 Diabetes | 6.2 | 18 | Citations (PDF) |
| 686 | Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis | 2.2 | 264 | Citations (PDF) |
| 687 | Diagnostic accuracy of 320-row multidetector computed tomography coronary angiography in the non-invasive evaluation of significant coronary artery disease | 2.2 | 187 | Citations (PDF) |
| 688 | Genetics of ACS and recurrent MI/cardiac death: are we getting to the heart of the (atherosclerotic) matter? | 2.2 | 0 | Citations (PDF) |
| 689 | Barriers to cardiovascular disease risk scoring and primary prevention in Europe | 0.5 | 87 | Citations (PDF) |
| 690 | Diabetes: Prognostic Value of CT Coronary Angiography—Comparison with a Nondiabetic Population | 8.7 | 71 | Citations (PDF) |
| 691 | Late stent malapposition: innocent phenomenon or major risk marker? reply | 2.2 | 2 | Citations (PDF) |
| 692 | Genetic determinants of adverse outcome (restenosis, malapposition and thrombosis) after stent implantation | 0.4 | 6 | Citations (PDF) |
| 693 | Unraveling the Directional Link between Adiposity and Inflammation: A Bidirectional Mendelian Randomization Approach | 4.0 | 133 | Citations (PDF) |
| 694 | Progression of brain atrophy and cognitive decline in diabetes mellitus | 1.0 | 204 | Citations (PDF) |
| 695 | KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study | 2.2 | 68 | Citations (PDF) |
| 696 | Activation of Hemostasis and Decline in Cognitive Function in Older People | 6.0 | 40 | Citations (PDF) |
| 697 | Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy | 2.3 | 156 | Citations (PDF) |
| 698 | Automated Quantification of Stenosis Severity on 64-Slice CT | 6.1 | 60 | Citations (PDF) |
| 699 | Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology | 0.6 | 297 | Citations (PDF) |
| 700 | Clinical Application of CT Coronary Angiography: State of the Art | 0.9 | 26 | Citations (PDF) |
| 701 | The tolerability and efficacy of low-dose simvastatin in statin-intolerant patients | 2.7 | 11 | Citations (PDF) |
| 702 | Incremental value of subclinical left ventricular systolic dysfunction for the identification of patients with obstructive coronary artery disease | 2.9 | 79 | Citations (PDF) |
| 703 | Lipoprotein-associated phospholipase A2, inflammatory biomarkers, and risk of cardiovascular disease in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) | 1.5 | 25 | Citations (PDF) |
| 704 | Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials | 62.1 | 2,280 | Citations (PDF) |
| 705 | TRAF1/C5polymorphism is not associated with increased mortality in rheumatoid arthritis: two large longitudinal studies | 3.9 | 17 | Citations (PDF) |
| 706 | Lipid goals among patients with diabetes or metabolic syndrome: Lipid Treatment Assessment Project (L-TAP) 2 | 2.1 | 17 | Citations (PDF) |
| 707 | Relationship between obstructive coronary artery disease and abnormal stress testing in patients with paroxysmal or persistent atrial fibrillation | 1.2 | 30 | Citations (PDF) |
| 708 | The 5352 A allele of the pro-inflammatory caspase-1 gene predicts late-acquired stent malapposition in STEMI patients treated with sirolimus stents | 1.2 | 3 | Citations (PDF) |
| 709 | Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease | 2.2 | 163 | Citations (PDF) |
| 710 | Reduced Glomerular Filtration Rate and Its Association with Clinical Outcome in Older Patients at Risk of Vascular Events: Secondary Analysis | 8.0 | 61 | Citations (PDF) |
| 711 | Both Paraoxonase-1 Genotype and Activity Do Not Predict the Risk of Future Coronary Artery Disease; the EPIC-Norfolk Prospective Population Study | 2.3 | 54 | Citations (PDF) |
| 712 | Risk factors and time delay associated with cardiac device infections: Leiden device registry | 3.9 | 216 | Citations (PDF) |
| 713 | Leukocyte Cathepsin S Is a Potent Regulator of Both Cell and Matrix Turnover in Advanced Atherosclerosis | 6.0 | 50 | Citations (PDF) |
| 714 | Endothelial Dysfunction in Diabetic Patients with Abnormal Myocardial Perfusion in the Absence of Epicardial Obstructive Coronary Artery Disease | 5.1 | 16 | Citations (PDF) |
| 715 | Prevalence of Coronary Artery Disease Assessed by Multislice Computed Tomography Coronary Angiography in Patients With Paroxysmal or Persistent Atrial Fibrillation | 2.9 | 76 | Citations (PDF) |
| 716 | Adipocytokines and risk of stroke in older people: a nested case–control study | 4.9 | 58 | Citations (PDF) |
| 717 | Differences in Atherosclerotic Plaque Burden and Morphology Between Type 1 and 2 Diabetes as Assessed by Multislice Computed Tomography | 6.2 | 45 | Citations (PDF) |
| 718 | The current status of interventions aiming at reducing sudden cardiac death in dialysis patients | 2.2 | 39 | Citations (PDF) |
| 719 | Multislice computed tomography coronary angiography for risk stratification in patients with an intermediate pretest likelihoodHeart, 2009, 95, 1607-1611 | 3.9 | 48 | Citations (PDF) |
| 720 | PPARγ Variant Influences Angiographic Outcome and 10-Year Cardiovascular Risk in Male Symptomatic Coronary Artery Disease Patients | 6.2 | 29 | Citations (PDF) |
| 721 | Plaque type and composition as evaluated non-invasively by MSCT angiography and invasively by VH IVUS in relation to the degree of stenosisHeart, 2009, 95, 1990-1996 | 3.9 | 45 | Citations (PDF) |
| 722 | Leptin Predicts Diabetes but Not Cardiovascular Disease | 6.2 | 77 | Citations (PDF) |
| 723 | Apolipoprotein E Genotype, Plasma Cholesterol, and Cancer: A Mendelian Randomization Study | 3.3 | 58 | Citations (PDF) |
| 724 | Lipid Treatment Assessment Project 2 | 18.0 | 304 | Citations (PDF) |
| 725 | High Innate Production Capacity of Proinflammatory Cytokines Increases Risk for Death from Cancer: Results of the PROSPER Study | 6.8 | 25 | Citations (PDF) |
| 726 | p27
kip1
–838C>A Single Nucleotide Polymorphism Is Associated With Restenosis Risk After Coronary Stenting and Modulates p27
kip1
Promoter Activity | 18.0 | 29 | Citations (PDF) |
| 727 | Usefulness of Peak Troponin-T to Predict Infarct Size and Long-Term Outcome in Patients With First Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention | 1.8 | 71 | Citations (PDF) |
| 728 | Usefulness of Echocardiographic Assessment of Cardiac and Ascending Aorta Calcific Deposits to Predict Coronary Artery Calcium and Presence and Severity of Obstructive Coronary Artery Disease | 1.8 | 24 | Citations (PDF) |
| 729 | Comparison of Non-Invasive Multi-Slice Computed Tomography Coronary Angiography Versus Invasive Coronary Angiography and Fractional Flow Reserve for the Evaluation of Men With Known Coronary Artery Disease††Conflicts of interest: Dr. Schalij received grants from Biotronik, Nijmegen, The Netherlands; Medtronic, Inc., Tolochenaz, Switzerland; and Boston Scientific Corporation, Maastricht, The Netherlands. Dr. Pundziute receives grants from Toshiba Medical Systems Europe, Zoetermeer, The Netherlands. Dr. Bax r | 1.8 | 17 | Citations (PDF) |
| 730 | Relation Between Framingham Risk Categories and the Presence of Functionally Relevant Coronary Lesions as Determined on Multislice Computed Tomography and Stress Testing | 1.8 | 6 | Citations (PDF) |
| 731 | Usefulness of Carotid Intima-Media Thickness in Patients With Diabetes Mellitus as a Predictor of Coronary Artery Disease | 1.8 | 29 | Citations (PDF) |
| 732 | Validation and reproducibility of aortic pulse wave velocity as assessed with velocity‐encoded MRI | 3.4 | 192 | Citations (PDF) |
| 733 | Novel clinical applications of state-of-the-art multi-slice computed tomography | 1.2 | 5 | Citations (PDF) |
| 734 | Coronary angiography enhancement for visualization | 1.2 | 12 | Citations (PDF) |
| 735 | Type 2 diabetes is associated with more advanced coronary atherosclerosis on multislice computed tomography and virtual histology intravascular ultrasound | 1.8 | 35 | Citations (PDF) |
| 736 | Prevalence of coronary artery disease across the Framingham risk categories: coronary artery calcium scoring and MSCT coronary angiography | 1.8 | 26 | Citations (PDF) |
| 737 | The value of multi-slice-computed tomography coronary angiography for risk stratification | 1.8 | 18 | Citations (PDF) |
| 738 | The dual PPARα/γ agonist tesaglitazar blocks progression of pre‐existing atherosclerosis in APOE*3Leiden.CETP transgenic mice | 6.3 | 35 | Citations (PDF) |
| 739 | A genome wide association analysis in the GENDER study | 1.3 | 11 | Citations (PDF) |
| 740 | PXR agonism decreases plasma HDL levels in ApoE⁎3-Leiden.CETP mice | 2.4 | 39 | Citations (PDF) |
| 741 | Effect of EPO administration on myocardial infarct size in patients with non-STE acute coronary syndromes; results from a pilot study | 2.2 | 33 | Citations (PDF) |
| 742 | Coronary collaterals improve prognosis in patients with ischemic heart disease | 2.2 | 77 | Citations (PDF) |
| 743 | Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2 | 2.9 | 41 | Citations (PDF) |
| 744 | Paraoxonase Variants Relate to 10-Year Risk in Coronary Artery Disease | 2.3 | 75 | Citations (PDF) |
| 745 | Prognostic Value of Multislice Computed Tomography and Gated Single-Photon Emission Computed Tomography in Patients With Suspected Coronary Artery Disease | 2.3 | 317 | Citations (PDF) |
| 746 | Myocardial Infarction Occurs with a Similar 24 h Pattern in the 4G/5G Versions of Plasminogen Activator Inhibitor-1 | 1.9 | 4 | Citations (PDF) |
| 747 | Mannose binding lectin deficiency and triglyceride-rich lipoprotein metabolism in normolipidemic subjects | 1.5 | 15 | Citations (PDF) |
| 748 | PCV107 ECONOMIC EVALUATION OF EZETIMIBE COMBINED WITH SIMVASTATIN FOR TREATMENT OF PRIMARY HYPERCHOLESTEROLAEMIA | 1.9 | 0 | Citations (PDF) |
| 749 | Head-to-head comparison between bicycle exercise testing and coronary calcium score and coronary stenoses on multislice computed tomography | 1.2 | 6 | Citations (PDF) |
| 750 | Incremental prognostic value of multi-slice computed tomography coronary angiography over coronary artery calcium scoring in patients with suspected coronary artery disease | 2.2 | 149 | Citations (PDF) |
| 751 | Pravastatin and cognitive function in the elderly. Results of the PROSPER study | 3.4 | 276 | Citations (PDF) |
| 752 | Assessment of global left ventricular function and volumes with 320-row multidetector computed tomography: A comparison with 2D-echocardiography | 1.8 | 36 | Citations (PDF) |
| 753 | Assessment of obstruction length and optimal viewing angle from biplane X-ray angiograms | 1.2 | 40 | Citations (PDF) |
| 754 | Are Markers of Inflammation More Strongly Associated with Risk for Fatal Than for Nonfatal Vascular Events? | 8.0 | 93 | Citations (PDF) |
| 755 | Post-intervention IVUS is not predictive for very late in-stent thrombosis in drug-eluting stents | 1.3 | 4 | Citations (PDF) |
| 756 | Impact of sirolimus-eluting stent implantation compared to bare-metal stent implantation for acute myocardial infarction on coronary plaque composition at nine months follow-up: a Virtual Histology intravascular ultrasound analysis. Results from the Leiden MISSION! intervention study | 3.0 | 6 | Citations (PDF) |
| 757 | Stent Malapposition After Sirolimus-Eluting and Bare-Metal Stent Implantation in Patients with ST-Segment Elevation Myocardial Infarction | 3.0 | 81 | Citations (PDF) |
| 758 | Non-invasive cardiac imaging techniques and vascular tools for the assessment of cardiovascular disease in type 2 diabetes mellitus | 7.5 | 65 | Citations (PDF) |
| 759 | Estimating effects of rare haplotypes on failure time using a penalized Cox proportional hazards regression model | 2.8 | 7 | Citations (PDF) |
| 760 | Platelet receptor P2RY12 haplotypes predict restenosis after percutaneous coronary interventions | 4.5 | 33 | Citations (PDF) |
| 761 | Head-to-Head Comparison of Coronary Plaque Evaluation Between Multislice Computed Tomography and Intravascular Ultrasound Radiofrequency Data Analysis | 3.0 | 138 | Citations (PDF) |
| 762 | Different manifestations of coronary artery disease by stress SPECT myocardial perfusion imaging, coronary calcium scoring, and multislice CT coronary angiography in asymptomatic patients with type 2 diabetes mellitus | 1.8 | 70 | Citations (PDF) |
| 763 | Epigenetic histone acetylation modifiers in vascular remodelling – new targets for therapy in cardiovascular disease | 1.3 | 10 | Citations (PDF) |
| 764 | Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation | 2.9 | 110 | Citations (PDF) |
| 765 | Reduced leucocyte cholesteryl ester transfer protein expression in acute coronary syndromes | 7.3 | 6 | Citations (PDF) |
| 766 | Anatomic Correlates of a Normal Perfusion Scan Using 64-Slice Computed Tomographic Coronary Angiography | 1.8 | 44 | Citations (PDF) |
| 767 | Relation of Epicardial Adipose Tissue to Coronary Atherosclerosis | 1.8 | 185 | Citations (PDF) |
| 768 | Lymphotoxin-alpha C804A polymorphism is a risk factor for stroke. The PROSPER study | 3.7 | 9 | Citations (PDF) |
| 769 | Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statins | 2.1 | 67 | Citations (PDF) |
| 770 | Statins for Secondary Prevention in Elderly Patients | 2.3 | 337 | Citations (PDF) |
| 771 | Sirolimus-Eluting Stents Versus Bare-Metal Stents in Patients With ST-Segment Elevation Myocardial Infarction: 9-Month Angiographic and Intravascular Ultrasound Results and 12-Month Clinical Outcome | 2.3 | 150 | Citations (PDF) |
| 772 | Noninvasive Evaluation With Multislice Computed Tomography in Suspected Acute Coronary Syndrome | 2.3 | 179 | Citations (PDF) |
| 773 | Diagnostic Accuracy of 64-Slice Computed Tomography Coronary Angiography | 2.3 | 1,207 | Citations (PDF) |
| 774 | Invasive Versus Noninvasive Evaluation of Coronary Artery Disease | 6.1 | 21 | Citations (PDF) |
| 775 | Niacin Increases HDL by Reducing Hepatic Expression and Plasma Levels of Cholesteryl Ester Transfer Protein in
APOE*3Leiden.CETP
Mice | 6.0 | 170 | Citations (PDF) |
| 776 | Dexamethasone-eluting stents for the prevention of in-stent restenosis: Evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients | 2.2 | 7 | Citations (PDF) |
| 777 | CCL3 (MIP-1α) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events | 3.8 | 67 | Citations (PDF) |
| 778 | Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo | 2.1 | 29 | Citations (PDF) |
| 779 | Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice | 1.5 | 77 | Citations (PDF) |
| 780 | High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants | 1.5 | 57 | Citations (PDF) |
| 781 | Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER | 1.5 | 80 | Citations (PDF) |
| 782 | Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population | 1.5 | 65 | Citations (PDF) |
| 783 | Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies | 62.1 | 438 | Citations (PDF) |
| 784 | The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study | 2.1 | 42 | Citations (PDF) |
| 785 | ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients | 2.1 | 28 | Citations (PDF) |
| 786 | Torcetrapib Does Not Reduce Atherosclerosis Beyond Atorvastatin and Induces More Proinflammatory Lesions Than Atorvastatin | 18.0 | 94 | Citations (PDF) |
| 787 | CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interaction | 2.2 | 99 | Citations (PDF) |
| 788 | Gender influence on the diagnostic accuracy of 64-slice multislice computed tomography coronary angiography for detection of obstructive coronary artery disease | 3.9 | 54 | Citations (PDF) |
| 789 | Genetic variation in the interleukin-1 -converting enzyme associates with cognitive function. The PROSPER studyBrain, 2008, 131, 1069-1077 | 8.4 | 69 | Citations (PDF) |
| 790 | Multi-slice computed tomography coronary angiography for ruling out suspected coronary artery disease: what is the prevalence of a normal study in a general clinical population? | 2.2 | 39 | Citations (PDF) |
| 791 | Evaluation of plaque characteristics in acute coronary syndromes: non-invasive assessment with multi-slice computed tomography and invasive evaluation with intravascular ultrasound radiofrequency data analysis | 2.2 | 222 | Citations (PDF) |
| 792 | Seven Lipoprotein Lipase Gene Polymorphisms, Lipid Fractions, and Coronary Disease: A HuGE Association Review and Meta-Analysis | 3.3 | 128 | Citations (PDF) |
| 793 | Statins: established indications and controversial subgroupsHeart, 2008, 94, 1656-1662 | 3.9 | 9 | Citations (PDF) |
| 794 | Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes | 3.9 | 146 | Citations (PDF) |
| 795 | Negative effects of rofecoxib treatment on cardiac function after ischemia-reperfusion injury in APOE*3Leiden mice are prevented by combined treatment with thromboxane prostanoid-receptor antagonist S18886 (terutroban)* | 0.5 | 36 | Citations (PDF) |
| 796 | Are elevated circulating intercellular adhesion molecule 1 levels more strongly predictive of diabetes than vascular risk? Outcome of a prospective study in the elderly | 7.5 | 18 | Citations (PDF) |
| 797 | THE AUTHORS REPLY | 3.3 | 2 | Citations (PDF) |
| 798 | Aging, Retirement, and Changes in Physical Activity: Prospective Cohort Findings from the GLOBE Study | 3.3 | 145 | Citations (PDF) |
| 799 | Pravastatin Decreases Wall Shear Stress and Blood Velocity in the Internal Carotid Artery Without Affecting Flow Volume | 5.9 | 21 | Citations (PDF) |
| 800 | Inhibition of neointima formation by local delivery of estrogen receptor alpha and beta specific agonists | 5.5 | 21 | Citations (PDF) |
| 801 | Activation of Nuclear Receptor Nur77 by 6-Mercaptopurine Protects Against Neointima Formation | 18.0 | 71 | Citations (PDF) |
| 802 | Multi‐slice computed tomography in the evaluation of patients with acute chest pain | 0.6 | 32 | Citations (PDF) |
| 803 | C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) | 18.0 | 116 | Citations (PDF) |
| 804 | Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expression | 3.6 | 91 | Citations (PDF) |
| 805 | Role of the Apolipoprotein B–Apolipoprotein A-I Ratio in Cardiovascular Risk Assessment: A Case–Control Analysis in EPIC-Norfolk | 9.6 | 143 | Citations (PDF) |
| 806 | Olmesartan and pravastatin additively reduce development of atherosclerosis in APOE*3Leiden transgenic mice | 2.1 | 27 | Citations (PDF) |
| 807 | Noninvasive Assessment of Left Ventricular Function Prior to and 6 Months After Renal Transplantation | 0.7 | 16 | Citations (PDF) |
| 808 | MISSION!: Optimization of acute and chronic care for patients with acute myocardial infarction | 2.9 | 121 | Citations (PDF) |
| 809 | Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: A systematic review and meta-analysis | 2.9 | 396 | Citations (PDF) |
| 810 | Assessment of left ventricular volumes and ejection fraction with 16-slice multi-slice computed tomography; comparison with 2D-echocardiography | 2.2 | 32 | Citations (PDF) |
| 811 | The effect of interleukin-10 knock-out and overexpression on neointima formation in hypercholesterolemic APOE*3-Leiden mice | 1.5 | 38 | Citations (PDF) |
| 812 | Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol | 2.1 | 41 | Citations (PDF) |
| 813 | A Randomized, Placebo‐Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacodynamic Interaction of Coadministered Amlodipine and Atorvastatin in 1660 Patients With Concomitant Hypertension and Dyslipidemia: The Respond Trial | 1.9 | 58 | Citations (PDF) |
| 814 | Differences in plaque composition and distribution in stable coronary artery disease versus acute coronary syndromes; non‐invasive evaluation with multi‐slice computed tomography | 0.6 | 98 | Citations (PDF) |
| 815 | Prognostic Value of Multislice Computed Tomography Coronary Angiography in Patients With Known or Suspected Coronary Artery Disease | 2.3 | 466 | Citations (PDF) |
| 816 | Usefulness of 64-Slice Multislice Computed Tomography Coronary Angiography to Assess In-Stent Restenosis | 2.3 | 146 | Citations (PDF) |
| 817 | The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions | 4.1 | 10 | Citations (PDF) |
| 818 | Impact of coronary calcium score on diagnostic accuracy of multislice computed tomography coronary angiography for detection of coronary artery disease | 1.8 | 31 | Citations (PDF) |
| 819 | The current status of multislice computed tomography in the diagnosis and prognosis of coronary artery disease | 1.8 | 14 | Citations (PDF) |
| 820 | Cardiovascular metabolic syndrome ? an interplay of, obesity, inflammation, diabetes and coronary heart disease | 4.5 | 188 | Citations (PDF) |
| 821 | Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC‐Norfolk Prospective Population Study | 7.3 | 79 | Citations (PDF) |
| 822 | Association Between Apolipoprotein E
4
and Cognitive Decline in Elderly Adults | 2.9 | 122 | Citations (PDF) |
| 823 | Cyphering the Complexity of Coronary Artery Disease Using the Syntax Score to Predict Clinical Outcome in Patients With Three-Vessel Lumen Obstruction Undergoing Percutaneous Coronary Intervention | 1.8 | 270 | Citations (PDF) |
| 824 | Genetic Variation in the Interleukin-10 Gene Promoter and Risk of Coronary and Cerebrovascular Events: The PROSPER Study | 4.0 | 43 | Citations (PDF) |
| 825 | The Routine Electrocardiogram for Cardiovascular Risk Stratification in Old Age: The Leiden 85‐Plus Study | 2.9 | 25 | Citations (PDF) |
| 826 | Modulation of calcification of vascular smooth muscle cells in culture by calcium antagonists, statins, and their combination | 3.1 | 52 | Citations (PDF) |
| 827 | C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: The EPIC-Norfolk prospective population study 1993–2003 | 1.5 | 163 | Citations (PDF) |
| 828 | Relationship Between Noninvasive Coronary Angiography With Multi-Slice Computed Tomography and Myocardial Perfusion Imaging | 2.3 | 460 | Citations (PDF) |
| 829 | Apoliprotein-E polymorphism and response to pravastatin in men with coronary artery disease (REGRESS) | 1.3 | 30 | Citations (PDF) |
| 830 | Anti-Atherosclerotic Effect of Amlodipine, Alone and in Combination With Atorvastatin, in APOE*3-Leiden/hCRP Transgenic Mice | 2.0 | 23 | Citations (PDF) |
| 831 | Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1 | 1.2 | 32 | Citations (PDF) |
| 832 | Inflammation and apoptosis genes and the risk of restenosis after percutaneous coronary intervention | 1.2 | 15 | Citations (PDF) |
| 833 | Common variants of multiple genes that control reverse cholesterol transport together explain only a minor part of the variation of HDL cholesterol levels | 2.1 | 45 | Citations (PDF) |
| 834 | Lipoprotein (a) and risk of cardiovascular disease in patients with metabolic syndrome in a population of familial hypercholesterolaemia | 7.3 | 3 | Citations (PDF) |
| 835 | Assessment of global and regional left ventricular function and volumes with 64-slice MSCT: A comparison with 2D echocardiography | 1.8 | 78 | Citations (PDF) |
| 836 | Do risk factors influence the diagnostic accuracy of noninvasive coronary angiography with multislice computed tomography? | 1.8 | 21 | Citations (PDF) |
| 837 | Local Cre-Mediated Gene Recombination in Vascular Smooth Muscle Cells in Mice | 1.8 | 12 | Citations (PDF) |
| 838 | Global and regional left ventricular function: a comparison between gated SPECT, 2D echocardiography and multi-slice computed tomography | 5.5 | 32 | Citations (PDF) |
| 839 | Drug-eluting stents studies in mice: Do we need atherosclerosis to study restenosis? | 2.5 | 10 | Citations (PDF) |
| 840 | Diagnostic Accuracy of 64-Slice Multislice Computed Tomography in the Noninvasive Evaluation of Significant Coronary Artery Disease | 1.8 | 218 | Citations (PDF) |
| 841 | Role of Calcified Spots Detected by Intravascular Ultrasound in Patients With ST-Segment Elevation Acute Myocardial Infarction | 1.8 | 16 | Citations (PDF) |
| 842 | Simultaneous estimation of gene-gene and gene-environment interactions for numerous loci using double penalized log–likelihood | 3.1 | 13 | Citations (PDF) |
| 843 | Dual PPARα/γ Agonist Tesaglitazar Reduces Atherosclerosis in Insulin-Resistant and Hypercholesterolemic ApoE*3Leiden Mice | 6.0 | 47 | Citations (PDF) |
| 844 | Advances in the noninvasive evaluation of coronary artery disease with multislice computed tomography | 2.0 | 4 | Citations (PDF) |
| 845 | Global and regional left ventricular function assessment with 16-detector row CT: Comparison with echocardiography and cardiovascular magnetic resonance | 2.1 | 73 | Citations (PDF) |
| 846 | Lesional Overexpression of Matrix Metalloproteinase-9 Promotes Intraplaque Hemorrhage in Advanced Lesions But Not at Earlier Stages of Atherogenesis | 6.0 | 201 | Citations (PDF) |
| 847 | Lipoprotein Lipase S447X | 6.0 | 150 | Citations (PDF) |
| 848 | Cholesteryl Ester Transfer Protein Decreases High-Density Lipoprotein and Severely Aggravates Atherosclerosis in
APOE*3-Leiden
Mice | 6.0 | 229 | Citations (PDF) |
| 849 | Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention | 3.8 | 37 | Citations (PDF) |
| 850 | Surrogate markers for atherosclerotic disease | 4.0 | 48 | Citations (PDF) |
| 851 | Genetic variation in the rate-limiting enzyme in cholesterol catabolism (cholesterol 7α-hydroxylase) influences the progression of atherosclerosis and risk of new clinical events | 6.2 | 32 | Citations (PDF) |
| 852 | Hemodynamic evaluation of saphenous vein coronary artery bypass grafts: Relative merits of Doppler flow velocity and SPECT perfusion imaging | 1.8 | 17 | Citations (PDF) |
| 853 | LDL-C/HDL-C ratio in patients with coronary artery disease and low HDL-C: the RADAR study | 3.0 | 0 | Citations (PDF) |
| 854 | Polymorphisms in APOA1 and LPL genes are statistically independently associated with fasting TG in men with CAD | 3.0 | 21 | Citations (PDF) |
| 855 | Cardiac multidetector-row computed tomography in patients with unstable angina | 1.8 | 69 | Citations (PDF) |
| 856 | Noninvasive coronary imaging and assessment of left ventricular function using 16-slice computed tomography | 1.8 | 123 | Citations (PDF) |
| 857 | Effect of Intracoronary Aqueous Oxygen on Left Ventricular Remodeling After Anterior Wall ST-Elevation Acute Myocardial Infarction | 1.8 | 22 | Citations (PDF) |
| 858 | Early administration of abciximab in patients with acute myocardial infarction improves angiographic and clinical outcome after primary angioplasty | 1.7 | 7 | Citations (PDF) |
| 859 | –455 G/A polymorphism and preprocedural plasma levels of fibrinogen show no association with the risk of clinical restenosis in patients with coronary stent placement | 4.1 | 20 | Citations (PDF) |
| 860 | Histopathologic alterations following local delivery of dexamethasone to inhibit restenosis in murine arteries | 5.5 | 24 | Citations (PDF) |
| 861 | Functional interaction between −629C/A, −971G/A and −1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP concentration in the REGRESS Study | 2.9 | 50 | Citations (PDF) |
| 862 | Cholesteryl Ester Transfer Protein TaqIB Variant, High-Density Lipoprotein Cholesterol Levels, Cardiovascular Risk, and Efficacy of Pravastatin Treatment | 18.0 | 305 | Citations (PDF) |
| 863 | Genetic Inflammatory Factors Predict Restenosis After Percutaneous Coronary Interventions | 18.0 | 68 | Citations (PDF) |
| 864 | Noninvasive Evaluation of the Coronary Arteries With Multislice Computed Tomography in Hypertensive Patients | 6.6 | 42 | Citations (PDF) |
| 865 | Two-Year Statin Therapy Does Not Alter the Progression of Intima-Media Thickness in Patients With Type 2 Diabetes Without Manifest Cardio-vascular Disease: Response to Cicero et al. | 6.2 | 3 | Citations (PDF) |
| 866 | Noninvasive evaluation of coronary artery disease: magnetic resonance imaging & multi-slice computed tomography | 1.0 | 0 | Citations (PDF) |
| 867 | No Effect of Statin Therapy on Silent Myocardial Ischemia in Patients With Type 2 Diabetes Without Manifest Cardiovascular Disease | 6.2 | 14 | Citations (PDF) |
| 868 | Tumor necrosis factor‐α plays an important role in restenosis development | 0.6 | 76 | Citations (PDF) |
| 869 | Serum Levels of Type II Secretory Phospholipase A2 and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women | 6.0 | 102 | Citations (PDF) |
| 870 | Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) | 18.0 | 120 | Citations (PDF) |
| 871 | No Effect of C-Reactive Protein on Early Atherosclerosis Development in Apolipoprotein E*3-Leiden/Human C-Reactive Protein Transgenic Mice | 6.0 | 120 | Citations (PDF) |
| 872 | Local perivascular delivery of anti-restenotic agents from a drug-eluting poly(-caprolactone) stent cuff | 12.1 | 64 | Citations (PDF) |
| 873 | LDL‐C/HDL‐C ratio in subjects with cardiovascular disease and a low HDL‐C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study | 2.1 | 60 | Citations (PDF) |
| 874 | Drug-eluting stents: results, promises and problems | 2.2 | 187 | Citations (PDF) |
| 875 | Comprehensive assessment of patients after coronary artery bypass grafting by 16-detector-row computed tomography | 2.9 | 88 | Citations (PDF) |
| 876 | Lipoprotein Lipase Gene Polymorphisms and the Risk of Target Vessel Revascularization After Percutaneous Coronary Intervention | 2.3 | 13 | Citations (PDF) |
| 877 | Diagnostic and prognostic value of non-invasive imaging in known or suspected coronary artery disease | 5.5 | 57 | Citations (PDF) |
| 878 | Pharmacogenetics of the CD14 endotoxin receptor polymorphism and progression of coronary atherosclerosis | 4.1 | 14 | Citations (PDF) |
| 879 | Assessment of parallel conductance for the trans-cardiac conductance method: can we use the hypertonic saline method with pulmonary artery injections? | 2.6 | 3 | Citations (PDF) |
| 880 | Dynamic Multislice Computed Tomography of Left Ventricular Function | 18.0 | 3 | Citations (PDF) |
| 881 | Additive Benefits of Pravastatin and Aspirin to Decrease Risks of Cardiovascular Disease | 8.1 | 98 | Citations (PDF) |
| 882 | Plasma Levels of Cholesteryl Ester Transfer Protein and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women | 18.0 | 216 | Citations (PDF) |
| 883 | Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy | 2.1 | 46 | Citations (PDF) |
| 884 | Overexpression of IL-18 Decreases Intimal Collagen Content and Promotes a Vulnerable Plaque Phenotype in Apolipoprotein-E–Deficient Mice | 6.0 | 98 | Citations (PDF) |
| 885 | Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent era | 2.2 | 57 | Citations (PDF) |
| 886 | Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS) | 3.0 | 104 | Citations (PDF) |
| 887 | Feasibility of assessment of coronary stent patency using 16-slice computed tomography | 1.8 | 162 | Citations (PDF) |
| 888 | Coronary Stent Imaging with Multidetector Row Computed Tomography | 0.0 | 7 | Citations (PDF) |
| 889 | Transcardiac conductance for continuous measurement of left ventricular volume: validation vs. angiography in patients | 5.2 | 4 | Citations (PDF) |
| 890 | The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome | 2.3 | 71 | Citations (PDF) |
| 891 | Functional significance of stenoses in coronary artery bypass grafts | 2.3 | 7 | Citations (PDF) |
| 892 | Genetic predictive factors in restenosis | 1.3 | 14 | Citations (PDF) |
| 893 | Simultaneous kidney-pancreas transplantation: The preferred option for patients with type I diabetes mellitus and approaching end-stage renal disease | 2.2 | 11 | Citations (PDF) |
| 894 | Interaction between a genetic variant of the platelet fibrinogen receptor and fibrinogen levels in determining the risk of cardiovascular events | 2.9 | 22 | Citations (PDF) |
| 895 | CETP gene variation: relation to lipid parameters and cardiovascular risk | 4.0 | 59 | Citations (PDF) |
| 896 | Functional significance of stenoses in coronary artery bypass graftsEvaluation by single-photon emission computed tomography perfusion imaging, cardiovascular magnetic resonance, and angiography | 2.3 | 17 | Citations (PDF) |
| 897 | Hepatic low-density lipoprotein receptor–related protein deficiency in mice increases atherosclerosis independent of plasma cholesterolBlood, 2004, 103, 3777-3782 | 4.8 | 38 | Citations (PDF) |
| 898 | An integrated evaluation of endothelial constitutive nitric oxide synthase polymorphisms and coronary artery disease in men | 6.2 | 28 | Citations (PDF) |
| 899 | M.542 LDL-C/HDL-C ratio in patients with coronary artery disease and low HDL-C: The radar study | 1.5 | 2 | Citations (PDF) |
| 900 | Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy | 2.1 | 5 | Citations (PDF) |
| 901 | Title is missing! | 0.0 | 5 | Citations (PDF) |
| 902 | Title is missing! | 0.0 | 1 | Citations (PDF) |
| 903 | Estimation of Multilocus Haplotype Effects Using Weighted Penalised Log-Likelihood: Analysis of Five Sequence Variations at the Cholesteryl Ester Transfer Protein Gene Locus | 1.1 | 42 | Citations (PDF) |
| 904 | A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studies | 1.5 | 37 | Citations (PDF) |
| 905 | Secondary prevention with folic acid: effects on clinical outcomes | 2.3 | 139 | Citations (PDF) |
| 906 | Effects of amlodipine, atorvastatin and combination of both on advanced atherosclerotic plaque in APOE*3-Leiden transgenic mice | 3.8 | 27 | Citations (PDF) |
| 907 | Secondary prevention in coronary heart disease patients with low HDL: which options do we have? | 2.2 | 4 | Citations (PDF) |
| 908 | Intravascular Ultrasound Guidance Improves Angiographic and Clinical Outcome of Stent Implantation for Long Coronary Artery Stenoses | 18.0 | 265 | Citations (PDF) |
| 909 | Variants of Toll-Like Receptor 4 Modify the Efficacy of Statin Therapy and the Risk of Cardiovascular Events | 18.0 | 216 | Citations (PDF) |
| 910 | Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C->A polymorphism and a novel promoter variant are independently associated with CETP concentration | 2.9 | 114 | Citations (PDF) |
| 911 | Value of Magnetic Resonance Imaging for the Noninvasive Detection of Stenosis in Coronary Artery Bypass Grafts and Recipient Coronary Arteries | 18.0 | 83 | Citations (PDF) |
| 912 | Rosuvastatin Reduces Atherosclerosis Development Beyond and Independent of Its Plasma Cholesterol–Lowering Effect in APOE*3-Leiden Transgenic Mice | 18.0 | 162 | Citations (PDF) |
| 913 | Differential Effects of Amlodipine and Atorvastatin Treatment and Their Combination on Atherosclerosis in ApoE*3-Leiden Transgenic Mice | 2.0 | 45 | Citations (PDF) |
| 914 | Myocardial Infarction in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) | 1.2 | 55 | Citations (PDF) |
| 915 | Association between thrombin-activatable fibrinolysis inhibitor (TAFI) and clinical outcome in patients with unstable angina pectoris | 4.1 | 39 | Citations (PDF) |
| 916 | Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629C->A polymorphism and a novel promoter variant are independently associated with CETP concentration | 2.9 | 2 | Citations (PDF) |
| 917 | Testing cognitive function in elderly populations: the PROSPER study | 6.3 | 139 | Citations (PDF) |
| 918 | Malignant Right Coronary Artery Anomaly Detected by Magnetic Resonance Coronary Angiography | 18.0 | 7 | Citations (PDF) |
| 919 | Continuous on-line measurement of absolute left ventricular volume by transcardiac conductance: Angiographic validation in sheep | 0.5 | 9 | Citations (PDF) |
| 920 | Raman spectroscopic investigation of atorvastatin, amlodipine, and both on atherosclerotic plaque development in APOE*3 Leiden transgenic mice | 1.5 | 35 | Citations (PDF) |
| 921 | Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial | 62.1 | 3,311 | Citations (PDF) |
| 922 | ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels | 2.1 | 99 | Citations (PDF) |
| 923 | A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics | 2.1 | 39 | Citations (PDF) |
| 924 | Detection of malignant right coronary artery anomaly by multi-slice CT coronary angiography | 3.6 | 28 | Citations (PDF) |
| 925 | A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: Evidence for publication bias | 2.9 | 39 | Citations (PDF) |
| 926 | A meta-analysis of the angiotensin-converting enzyme gene polymorphism and restenosis after percutaneous transluminal coronary revascularization: Evidence for publication bias | 2.9 | 0 | Citations (PDF) |
| 927 | Molecular genetics and gene expression in atherosclerosis | 2.2 | 45 | Citations (PDF) |
| 928 | Factor VII Polymorphisms and Myocardial Infarction: What Is Special in Italians? | 4.1 | 8 | Citations (PDF) |
| 929 | Hypertonic saline method accurately determines parallel conductance for dual-field conductance catheter | 3.5 | 108 | Citations (PDF) |
| 930 | Genetic aspects of restenosis after percutaneous coronary interventions;towards more tailored therapy | 2.2 | 36 | Citations (PDF) |
| 931 | Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS Trial) | 1.8 | 60 | Citations (PDF) |
| 932 | The −323Ins10 Polymorphism for Factor VII Is Not Associated with Coronary Atherosclerosis in Symptomatic Men | 2.3 | 9 | Citations (PDF) |
| 933 | Effects of amlodipine and atorvastatin on the development of atherosclerosis in ApoE*3-Leiden transgenic mice | 1.5 | 1 | Citations (PDF) |
| 934 | Tailored Therapy to Fit Individual Profiles: Genetics and Coronary Artery Disease | 4.0 | 9 | Citations (PDF) |
| 935 | Analysis of lipoprotein lipase haplotypes reveals associations not apparent from analysis of the constituent loci | 1.1 | 13 | Citations (PDF) |
| 936 | Title is missing! | 0.0 | 23 | Citations (PDF) |
| 937 | Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis | 1.8 | 135 | Citations (PDF) |
| 938 | The design of a prospective study of pravastatin in the elderly at risk (PROSPER) | 1.8 | 319 | Citations (PDF) |
| 939 | Title is missing! | 2.1 | 16 | Citations (PDF) |
| 940 | Clinical and Angiographic Outcome of Micro Stent II Implantation in Native Coronary Arteries | 1.8 | 6 | Citations (PDF) |
| 941 | Micro stent I, initial results, and six months follow-up by quantitative coronary angiography | 0.9 | 10 | Citations (PDF) |
| 942 | B-Mode Ultrasound Assessment of Pravastatin Treatment Effect on Carotid and Femoral Artery Walls and Its Correlations With Coronary Arteriographic Findings: A Report of the Regression Growth Evaluation Statin Study (REGRESS) | 2.3 | 241 | Citations (PDF) |
| 943 | Depressed heart rate variability is associated with events in patients with stable coronary artery disease and preserved left ventricular function | 2.9 | 65 | Citations (PDF) |
| 944 | −455G/A Polymorphism of the β-Fibrinogen Gene is Associated With the Progression of Coronary Atherosclerosis in Symptomatic Men | 6.0 | 156 | Citations (PDF) |
| 945 | The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary Atherosclerosis | 34.5 | 633 | Citations (PDF) |
| 946 | 1.P.43 A hepatic lipase promoter polymorphism (C-480T) abolishes insulin-sensitivity of hepatic lipase expression | 1.5 | 0 | Citations (PDF) |
| 947 | Modulation of Lipoprotein(a) Atherogenicity by High Density Lipoprotein Cholesterol Levels in Middle-Aged Men With Symptomatic Coronary Artery Disease and Normal to Moderately Elevated Serum Cholesterol fn1fn1This study was supported by Bristol-Myers Squibb Co., Princeton, New Jersey (REGRESS main study) and by Grant 94.032 from the Dutch Heart Foundation, Den Haag, The Netherlands [lipoprotein(a) substudy]. | 2.3 | 63 | Citations (PDF) |
| 948 | Common C-to-T Substitution at Position −480 of the Hepatic Lipase Promoter Associated With a Lowered Lipase Activity in Coronary Artery Disease Patients | 6.0 | 144 | Citations (PDF) |
| 949 | Value of Fast Gradient Echo Magnetic Resonance Angiography as an Adjunct to Coronary Arteriography in Detecting and Confirming the Course of Clinically Significant Coronary Artery Anomalies | 1.8 | 134 | Citations (PDF) |
| 950 | On the statistical modelling of coronary arteriographic data: dynamics of coronary atherosclerosis related to systemic and focal parameters 1997, 16, 2829-2841 | | 1 | Citations (PDF) |
| 951 | Functional Evaluation of Lipid-Lowering Therapy by Pravastatin in the Regression Growth Evaluation Statin Study (REGRESS) | 18.0 | 45 | Citations (PDF) |
| 952 | Thermolabile Methylenetetrahydrofolate Reductase in Coronary Artery Disease | 18.0 | 183 | Citations (PDF) |
| 953 | Correlations in pravastatin treatment effect between carotid and femoral intima-media thickness, and coronary artery stenosis | 2.3 | 1 | Citations (PDF) |
| 954 | Pravastatin reduces transient myocardial ischemia in patients with angina pectoris and significant CAD | 2.3 | 1 | Citations (PDF) |
| 955 | Evidence for a Synergistic Effect of Calcium Channel Blockers With Lipid-Lowering Therapy in Retarding Progression of Coronary Atherosclerosis in Symptomatic Patients With Normal to Moderately Raised Cholesterol Levels | 6.0 | 79 | Citations (PDF) |
| 956 | Micro stent,™ quantitative coronary angiography, and procedural results 1996, 38, 135-143 | | 6 | Citations (PDF) |
| 957 | The Influence of Angiographic Endpoints on the Outcome of Lipid Intervention Studies | 1.9 | 5 | Citations (PDF) |
| 958 | Reduction of Transient Myocardial Ischemia With Pravastatin in Addition to the Conventional Treatment in Patients With Angina Pectoris | 18.0 | 140 | Citations (PDF) |
| 959 | The Asp
9
Asn Mutation in the Lipoprotein Lipase Gene Is Associated With Increased Progression of Coronary Atherosclerosis | 18.0 | 104 | Citations (PDF) |
| 960 | Effect of pravastatin on progression and regression of coronary atherosclerosis and vessel wall changes in carotid and femoral arteries: A report from the regression growth evaluation statin study | 1.8 | 94 | Citations (PDF) |
| 961 | Heart rate variability profiles in symptomatic coronary artery disease and preserved left ventricular function: Relation to ventricular tachycardia and transient myocardial ischemia | 2.9 | 11 | Citations (PDF) |
| 962 | 769-5 Reduction of Silent Myocardial Ischemia by Pravastatin Additional to the Conventional Treatment of Patients with Angina Pectoris | 2.3 | 1 | Citations (PDF) |
| 963 | 769-2 Progression and Regression of Coronary Atherosclerosis Occur within the Same Patient During Placebo Treatment and During Lipid-Lowering Therapy with Pravastatin | 2.3 | 0 | Citations (PDF) |
| 964 | 769-1 The Influence of Pravastatin on Progression and Regression of Coronary Atherosclerosis in Men with Normal or Mildly Raised Serum Cholesterol. Results of the Regression Growth Evaluation Statin Study (REGRESS) | 2.3 | 0 | Citations (PDF) |
| 965 | Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels | 18.0 | 735 | Citations (PDF) |
| 966 | Reduction in Cardiovascular Events During Pravastatin Therapy | 18.0 | 243 | Citations (PDF) |
| 967 | Endothelial dysfunction and dyslipidemia: possible effects of lipid lowering and lipid modifying therapy | 9.1 | 24 | Citations (PDF) |
| 968 | Dipyridamole thallium-201 scintigraphy for improved detection of left anterior descending coronary artery stenosis in patients with left bundle branch block | 2.2 | 38 | Citations (PDF) |
| 969 | Pseudoaneurysm of a saphenous vein coronary artery bypass graft with a fistula draining into the right atrium | 2.9 | 27 | Citations (PDF) |
| 970 | Genome-wide Association Study of the Postprandial Triglyceride Response Yields Common Genetic Variation in Hepatic Lipase (LIPC) | 2.9 | 3 | Citations (PDF) |
| 971 | Apolipoprotein C3 and risk of cardiovascular events and death in patients on optimized statin treatment after recent acute coronary syndrome | 2.0 | 8 | Citations (PDF) |
| 972 | Bridging Therapy and Risk of Bleeding and Thrombosis in Continuous-Flow Left Ventricular Assist Device Patients: A Quasi-Experimental Study | 1.8 | 4 | Citations (PDF) |
| 973 | Multiplex Apolipoprotein Panel Improves Cardiovascular Event Prediction and Cardiovascular Outcome by Identifying Patients Who Benefit From Targeted PCSK9 Inhibitor Therapy | 6.0 | 3 | Citations (PDF) |
| 974 | Oxidized Phospholipids, Lipoprotein(a), and Cardiovascular Outcomes After Acute Coronary Syndrome | 18.0 | 5 | Citations (PDF) |
| 975 | Genetic risk factors for MASLD/MASH and cardiovascular disease in elderly individuals | 1.5 | 0 | Citations (PDF) |
| 976 | Prognostic Value of NT-proBNP in Patients Treated With Allogeneic Stem Cell Transplantation | 1.3 | 0 | Citations (PDF) |
| 977 | Clinical Impact of Device-Based Multisensory Monitoring in Heart Failure | 4.4 | 1 | Citations (PDF) |
| 978 | Association Between High-Density Lipoprotein Characteristics and Hemostatic Parameters in the Netherlands Epidemiology of Obesity (NEO) Study—Brief Report | 6.0 | 1 | Citations (PDF) |
| 979 | Large language models in venous thromboembolism care: time to move from hype to implementation | 3.8 | 0 | Citations (PDF) |
| 980 | Reply to Letter: “Bridging in Left Ventricular Assist Device Patients” | 1.8 | 0 | Citations (PDF) |
| 981 | Efficacy and workload implications of the Triage-HF™ algorithm in a nurse- and allied professional-led heart failure care pathway | 1.3 | 1 | Citations (PDF) |
| 982 | Generational changes in cardiometabolic disease incidence by risk factor strata in the UK Biobank | 2.8 | 0 | Citations (PDF) |
